<SEC-DOCUMENT>0000950103-25-014261.txt : 20251104
<SEC-HEADER>0000950103-25-014261.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104161503
ACCESSION NUMBER:		0000950103-25-014261
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251449235

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251449236

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236924_424b2-us2523777d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Filed
    Pursuant to Rule 424(b)(2)</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Registration
    Statement Nos. 333-270327 and 333-270327-01</B></FONT></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 79%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>October 31, 2025</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Medium-Term Senior
    Notes, Series N </B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Pricing Supplement
    No. 2025-USNCH29094 to Product Supplement No. EA-08-02<BR>
    dated March 23, 2023 and Prospectus Supplement and Prospectus each dated March 7, 2023 </B></FONT></P></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 21%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 55px; width: 81px"></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #EDEFEE">
    <TD STYLE="padding: 4pt; width: 1%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="padding: 4pt; vertical-align: top; width: 99%">
    <P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Citigroup Global Markets
Holdings Inc.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>All Payments Due from Citigroup
Global Markets Holdings Inc. Fully and Unconditionally Guaranteed by Citigroup Inc.</B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding: 4pt; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding: 4pt; width: 99%">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable
with Contingent Coupon and Contingent Downside</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel
Corporation due November 2, 2028</B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
to Intel Corporation (the &ldquo;underlying&rdquo;) </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
ordinary debt securities, the securities do not provide for fixed payments of interest, do not repay a fixed amount of principal at maturity
and are subject to potential automatic redemption prior to maturity upon the terms described below.&nbsp;&nbsp;Whether the securities
pay a contingent coupon, whether the securities are automatically redeemed prior to maturity and, if they are not automatically redeemed,
whether you are repaid the stated principal amount of your securities at maturity will depend in each case on the closing value of the
underlying on the relevant calculation day.&nbsp;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;&nbsp;Contingent
Coupon.</B>&nbsp;&nbsp;The securities will pay a contingent coupon on a quarterly basis until the earlier of maturity or automatic redemption
if, <B>and only if</B>, the closing value of the underlying on the relevant calculation day is greater than or equal to the coupon threshold
value.&nbsp;&nbsp;However, if the closing value of the underlying on a calculation day is less than the coupon threshold value, you will
not receive any contingent coupon on the relevant contingent coupon date.&nbsp;&nbsp;If the closing value of the underlying is less than
the coupon threshold value on every calculation day, you will not receive any contingent coupons throughout the entire term of the securities.
The contingent coupon rate is 15.50% per annum.</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;&nbsp;Automatic
Redemption.</B>&nbsp;&nbsp;If the closing value of the underlying on any potential autocall date from January 2026 to July 2028, inclusive,
is greater than or equal to the call threshold value, we will automatically redeem the securities for the stated principal amount <I>plus</I>
the related contingent coupon payment </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;&nbsp;Potential
Loss of Principal.</B>&nbsp;&nbsp;If the securities are not automatically redeemed prior to maturity, you will receive the stated principal
amount at maturity if, <B>and only if</B>, the closing value of the underlying on the final calculation day is greater than or equal
to the downside threshold value.&nbsp;&nbsp;If the closing value of the underlying on the final calculation day is less than the downside
threshold value, you will lose a significant portion, and possibly all, of the stated principal amount of your securities</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;The
coupon threshold value and downside threshold value for the underlying are each equal to 60% of the starting value</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;The
call threshold value for the underlying is equal to 90% of the starting value</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the securities are not automatically redeemed prior to maturity, you will have full downside exposure to the underlying from the starting
value if the closing value on the final calculation day is less than the downside threshold value, but you will not participate in any
appreciation of the underlying and will not receive any dividends on the underlying</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;All
payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.; if Citigroup
Global Markets Holdings Inc. and Citigroup Inc. default on their obligations, you could lose some or all of your investment</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.9pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;The
securities will not be listed on any securities exchange and, accordingly, may have limited or no liquidity.&nbsp;&nbsp;You should not
invest in the securities unless you are willing to hold them to maturity</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 12pt"><B>The securities
have complex features and investing in the securities involves risks not associated with an investment in conventional debt securities.
See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-8 and &ldquo;Risk Factors&rdquo; beginning on page PS-5 of the accompanying
product supplement and beginning on page S-1 of the accompanying prospectus supplement.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement or the accompanying product supplement, prospectus supplement and prospectus are truthful or complete. Any representation
to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The securities are unsecured debt obligations
issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. All payments due on the securities are subject to the
credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. None of Wells Fargo Securities, LLC (&ldquo;Wells Fargo&rdquo;)
or any of its affiliates will have any liability to the purchasers of the securities in the event Citigroup Global Markets Holdings Inc.
defaults on its obligations under the securities and Citigroup Inc. defaults on its guarantee obligations.&nbsp;&nbsp;The securities
are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency,
nor are they obligations of, or guaranteed by, a bank.</B></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 30%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Total</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Public Offering Price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$4,820,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Underwriting Discount and Commission<SUP>(2)(3)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$112,065.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Proceeds to Citigroup Global Markets Holdings Inc.<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$976.75</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$4,707,935.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(1) On the date of
this pricing supplement, the estimated value of the securities is $956.50 per security, which is less than the public offering price.&nbsp;&nbsp;The
estimated value of the securities is based on Citigroup Global Markets Inc.&rsquo;s (&ldquo;CGMI&rdquo;) proprietary pricing models and
our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the
price, if any, at which any person may be willing to buy the securities from you at any time after issuance.&nbsp;&nbsp;See &ldquo;Valuation
of the Securities&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(2) CGMI, an affiliate
of Citigroup Global Markets Holdings Inc., as the lead agent for the offering, has agreed to sell the securities to Wells Fargo, as agent.
Wells Fargo will receive an underwriting discount and commission of 2.325% ($23.25) for each security it sells. Wells Fargo may pay selected
dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name of the retail brokerage business of its affiliates,
Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), a fixed selling commission of 1.75% ($17.50) for
each security they sell.&nbsp;&nbsp;In addition to the selling commission allowed to WFA, Wells Fargo may pay $0.75 per security of the
underwriting discount and commission to WFA as a distribution expense fee for each security sold by WFA. The total underwriting discount
and commission and proceeds to Citigroup Global Markets Holdings Inc. shown above give effect to the actual underwriting discount and
commission provided for the sale of the securities.&nbsp;&nbsp;See &ldquo;Supplemental Plan of Distribution&rdquo; below and &ldquo;Use
of Proceeds and Hedging&rdquo; in the accompanying prospectus for further information regarding how we have hedged our obligations under
the securities.</FONT></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(3) In respect of
certain securities sold in this offering, CGMI may pay a fee of up to $3.00 per security to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the securities to other securities dealers.</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Citigroup
    Global Markets Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Wells
    Fargo Securities</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Terms
of the Securities</B></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Underlying:</B></FONT></TD>
    <TD STYLE="width: 75%; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">Intel Corporation. The &ldquo;closing value&rdquo; of the underlying on any date of determination is the stock closing price of its underlying stock on that day, as provided in the accompanying product supplement. The &ldquo;underlying stock&rdquo; for Intel Corporation is its shares of common stock. Please see the accompanying product supplement for more information.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Stated Principal Amount:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 per security. References in this pricing supplement to a &ldquo;security&rdquo; are to a security with a stated principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">November 5, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Calculation Days:</B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">The 30<SUP>th</SUP> day of each January, April, July and October, beginning in January 2026 and ending in October 2028, <I>provided</I> that the October 2028 calculation day will be the final calculation day. Each calculation day is subject to postponement if such date is not a trading day or certain market disruption events occur as described in the accompanying product supplement.&nbsp;&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Final Calculation Day: </B></FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">October 30, 2028, subject to postponement</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Maturity Date:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">November 2, 2028, subject to postponement as described in the accompanying product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Payment Dates:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">The third business day after each calculation day (as each such calculation day may be postponed), except that the contingent coupon payment date following the final calculation day will be the maturity date. </FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon at a per annum rate equal to the contingent coupon rate if and only if the closing value of the underlying on the immediately preceding calculation day is greater than or equal to the coupon threshold value. Each &ldquo;contingent coupon payment,&rdquo; if any, will be calculated per security as follows: ($1,000 &times; contingent coupon rate)/4. Any contingent coupon payment will be rounded to the nearest cent, with one-half cent rounded upward.&nbsp;&nbsp;<B>If the closing value of the underlying on any calculation day is less than the coupon threshold value, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">15.50% per annum </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-top: white 1pt solid; border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in; width: 25%"><FONT STYLE="font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="width: 75%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.1in; text-align: justify">If the securities are not automatically
redeemed prior to maturity, you will receive at maturity for each security you then hold (in addition to the contingent coupon due at
maturity, if any):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.35in; text-align: justify; text-indent: -0.25in">&squarf;&#9;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the closing value of the underlying on the final calculation day is <B>greater than or equal to</B> the downside threshold value: $1,000;
or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.35in; text-align: justify; text-indent: -0.25in">&squarf;&#9;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the closing value of the underlying on the final calculation day is <B>less than</B> the downside threshold value: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 25.65pt; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: white">$1,000
&times; the performance factor</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.1in; text-align: justify"><B>If the closing value of
the underlying on the final calculation day is less than the downside threshold value, you will receive significantly less than the stated
principal amount of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment at maturity.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Automatic Early Redemption:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">If, on any potential autocall date, the closing value of the underlying is greater than or equal to the call threshold value, each security you then hold will be automatically redeemed on the immediately following contingent coupon payment date for an amount in cash equal to $1,000 <I>plus</I> the related contingent coupon payment.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Potential Autocall Dates:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">Each calculation day beginning in January 2026 and ending in July 2028.&nbsp;&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Starting Value:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;$39.99, which is the closing value of the underlying on the pricing date.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Coupon Threshold Value:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.1in">&nbsp;&nbsp;$23.994, which is equal to 60% of the
starting value.</P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Downside Threshold Value:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.1in">&nbsp;&nbsp;$23.994, which is equal to 60% of the
starting value.</P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Call Threshold Value:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.1pt 0pt 0.1in">&nbsp;&nbsp;$35.991, which is equal to 90% of the
starting value.</P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Performance Factor: </B></FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the final calculation day <I>divided by</I> the starting value </FONT></TD></TR>
  <TR>
    <TD STYLE="background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">CGMI</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: white 1pt solid; background-color: #E0E3E2; padding-left: 0.1in"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">17331BRS0 / US17331BRS06</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Additional
    Information</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of the securities are set forth in the
accompanying product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying
product supplement, prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.&nbsp;&nbsp;For
example, the accompanying product supplement contains important information about how the closing value of the underlying will be determined
and other specified events with respect to the underlying. It is important that you read the accompanying product supplement, prospectus
supplement and prospectus together with this pricing supplement in connection with your investment in the securities.&nbsp;&nbsp;Certain
terms used but not defined in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we refer to &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; in this pricing supplement, we refer only to Citigroup Global Markets Holdings Inc. and not to any of its affiliates,
including Citigroup Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access the product supplement and prospectus
supplement and prospectus on the SEC website www.sec.gov as follows (or if such address has changed, by reviewing our filings for the
relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt">&bull;</TD><TD STYLE="text-align: justify">Product Supplement No. EA-08-02 dated March 23, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 0pt"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323004586/dp190173_424b2-wf0802.htm" STYLE="color: Blue; text-decoration: underline">https://www.sec.gov/Archives/edgar/data/200245/000095010323004586/dp190173_424b2-wf0802.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt">&bull;</TD><TD STYLE="text-align: justify">Prospectus Supplement and Prospectus each dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 0pt"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: Blue; text-decoration: underline">https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Investor
    Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are not appropriate for all investors.
The securities may be an appropriate investment for investors who:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek an investment with periodic contingent coupon payments equal to the amount indicated on the cover
hereof until the earlier of maturity or automatic redemption, if, <B>and only if</B>, the closing value of the underlying on the relevant
calculation day is greater than or equal to the coupon threshold value;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">understand that if the closing value of the underlying on the final calculation day is less than the downside
threshold value, they will be fully exposed to the decline in the underlying from the starting value and will receive significantly less
than the stated principal amount, and possibly nothing, at maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to accept the risk that they may receive few or no contingent coupon payments over the term
of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">understand that the securities may be automatically redeemed prior to maturity and that the term of the
securities may be limited;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">understand and are willing to accept the full downside risks of the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to forgo participation in any appreciation of the underlying and dividends on the underlying;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to hold the securities to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities may not be an appropriate investment
for investors who:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek a liquid investment or are unable or unwilling to hold the securities to maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek full return of the stated principal amount of the securities at maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek a security with a fixed term;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to purchase securities with the estimated value set forth on the cover page;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the risk that the closing value of the underlying on the final calculation day
may be less than the downside threshold value;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek certainty of current income over the term of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek exposure to the upside performance of the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the risk of exposure to the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">prefer the lower risk of fixed income investments with comparable maturities issued by companies with
comparable credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Summary Risk Factors&rdquo; herein and the &ldquo;Risk Factors&rdquo; in the accompanying product supplement for risks related
to an investment in the securities. For more information about the underlying, please see the information provided below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Determining
    Payment On A Contingent Coupon Payment Date and at Maturity</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the securities have not been previously automatically
redeemed, on each contingent coupon payment date, you will either receive a contingent coupon payment or you will not receive a contingent
coupon payment, depending on the closing value of the underlying on the related calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determine whether a contingent coupon is paid
on the applicable contingent coupon payment date based on the closing value of the underlying on the relevant calculation day, as follows:&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 266px; width: 573px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the relevant calculation day were also a potential
autocall date and the closing value of the underlying on the relevant calculation day were greater than or equal to the call threshold
value, the securities would be automatically redeemed on the applicable contingent coupon payment date for an amount in cash equal to
$1,000 <I>plus</I> the related contingent coupon payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the maturity date, if the securities have not
been automatically redeemed prior to the maturity date, you will receive (in addition to the final contingent coupon payment, if any)
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 266px; width: 501px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Payout Profile</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following profile illustrates the potential
maturity payment amount on the securities (excluding the final contingent coupon payment, if any) for a range of hypothetical performances
of the underlying from the starting value to the closing value on the final calculation day, assuming the securities have not been automatically
redeemed prior to the maturity date. This graph has been prepared for purposes of illustration only. Your actual return on the securities
will depend on the actual closing value of the underlying on the final calculation day and whether you hold your securities to the maturity
date.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_001.gif" ALT="" STYLE="height: 430px; width: 663px"></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Summary
    Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities is significantly
riskier than an investment in conventional debt securities.&nbsp;&nbsp;The securities are subject to all of the risks associated with
an investment in our conventional debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default
on our obligations under the securities, and are also subject to risks associated with the underlying.&nbsp;&nbsp;Accordingly, the securities
are appropriate only for investors who are capable of understanding the complexities and risks of the securities.&nbsp;&nbsp;You should
consult your own financial, tax and legal advisors as to the risks of an investment in the securities and the appropriateness of the securities
in light of your particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of certain key risk
factors for investors in the securities.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks
relating to an investment in the securities contained in the section &ldquo;Risk Factors&rdquo; beginning on page PS-5 in the accompanying
product supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and
in the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report
on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You May Lose Some Or All Of Your Investment.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unlike conventional debt securities, the securities
do not provide for the repayment of the stated principal amount at maturity in all circumstances.&nbsp;&nbsp;If the securities are not
automatically redeemed prior to maturity, your maturity payment amount will depend on the closing value of the underlying on the final
calculation day.&nbsp;&nbsp;If the closing value of the underlying on the final calculation day is less than the downside threshold value,
you will lose 1% of the stated principal amount of the securities for every 1% by which the underlying has declined from the starting
value.&nbsp;&nbsp;There is no minimum maturity payment amount on the securities, and you may lose up to all of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You Will Not Receive Any Contingent Coupon
On The Contingent Coupon Payment Date Following Any Calculation Day On Which The Closing Value Of The Underlying Is Less Than The Coupon
Threshold Value.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A contingent coupon payment will be made on a
contingent coupon payment date if and only if the closing value of the underlying on the immediately preceding calculation day is greater
than or equal to the coupon threshold value. If the closing value of the underlying is less than the coupon threshold value on any calculation
day, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date. If the closing value
of the underlying is below the coupon threshold value on each calculation day, you will not receive any contingent coupon payments over
the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Higher Contingent Coupon Rates Are Associated
With Greater Risk.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities offer contingent coupon payments
at an annualized rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities
of the same maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities,
including the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the
risk that the securities will not be automatically redeemed and the value of what you receive at maturity may be significantly less than
the stated principal amount of your securities and may be zero. The volatility of the underlying is an important factor affecting these
risks. Greater expected volatility of the underlying as of the pricing date may result in a higher contingent coupon rate, but would also
represent a greater expected likelihood as of the pricing date that (i) the closing value of the underlying on one or more calculation
days will be less than the coupon threshold value, such that you will not receive one or more, or any, contingent coupon payments during
the term of the securities and (ii) the securities will not be automatically redeemed and the closing value of the underlying on the final
calculation day will be less than the downside threshold value, such that you will not be repaid the stated principal amount of your securities
at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You Will Not Receive Dividends Or Have Any Other Rights With Respect
To The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not receive any dividends with respect
to the underlying. This lost dividend yield may be significant over the term of the securities. The payment scenarios described in this
pricing supplement do not show any effect of lost dividend yield over the term of the securities. In addition, you will not have voting
rights or any other rights with respect to the underlying. If any change to the underlying is proposed, such as an amendment to the underlying&rsquo;s
organizational documents, you will not have the right to vote on such change. Any such change may adversely affect the market value of
the underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You May Not Be Adequately Compensated For Assuming
The Downside Risk Of The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The potential contingent coupon payments on the
securities are the compensation you receive for assuming the downside risk of the underlying, as well as all the other risks of the securities.
That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you currently anticipate. First, the actual yield
you realize on the securities could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo; and you may not receive
a contingent coupon payment on one or more, or any, of the contingent coupon payment dates. Second, the contingent coupon payments are
the compensation you receive not only for the downside risk of the underlying, but also for all of the other risks of the securities,
including the risk that the securities may be automatically redeemed prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s
credit risk.&nbsp;&nbsp;If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments
may turn out to be inadequate to compensate you for all the risks of the securities, including the downside risk of the underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Securities May Be Automatically Redeemed
Prior To Maturity, Limiting Your Opportunity To Receive Contingent Coupon Payments.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On any potential autocall date, the securities
will be automatically redeemed if the closing value of the underlying on that potential autocall date is greater than or equal to the
call threshold value. Thus, the term of the securities may be limited.&nbsp;&nbsp;If the securities are redeemed prior to maturity, you
will not receive any additional contingent coupon payments.&nbsp;&nbsp;Moreover, you may not be able to reinvest your funds in another
investment that provides a similar yield with a similar level of risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Securities Offer Downside Exposure To The
Underlying, But No Upside Exposure To The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not participate in any appreciation in
the value of the underlying over the term of the securities. Consequently, your return on the securities will be limited to the contingent
coupon payments you receive, if any, and may be significantly less than the return on the underlying over the term of the securities.
In addition, as an investor in the securities, you will not receive any dividends or other distributions or have any other rights with
respect to the underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Performance Of The Securities Will Depend
On The Closing Value Of The Underlying Solely On The Calculation Days, Which Makes The Securities Particularly Sensitive To Volatility
In The Closing Value Of The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whether the contingent coupon will be paid on
any given contingent coupon payment date and whether the securities will be automatically redeemed prior to maturity will depend on the
closing value of the underlying solely on the applicable calculation days, regardless of the closing value of the underlying on other
days during the term of the securities. If the securities are not automatically redeemed, what you receive at maturity will depend solely
on the closing value of the underlying on the final calculation day, and not on any other day during the term of the securities. Because
the performance of the securities depends on the closing value of the underlying on a limited number of dates, the securities will be
particularly sensitive to volatility in the closing value of the underlying. You should understand that the closing value of the underlying
has historically been highly volatile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Securities Are Subject To The Credit Risk
Of Citigroup Global Markets Holdings Inc. And Citigroup Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we default on our obligations under the securities
and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you under the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Securities Will Not Be Listed On Any Securities
Exchange And You May Not Be Able To Sell Them Prior To Maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities will not be listed on any securities
exchange. Therefore, there may be little or no secondary market for the securities.&nbsp;&nbsp;We have been advised that Wells Fargo currently
intends to make a secondary market in relation to the securities.&nbsp;&nbsp;However, Wells Fargo may suspend or terminate making a market
without notice, at any time and for any reason.&nbsp;&nbsp;If Wells Fargo suspends or terminates making a market, there may be no secondary
market at all for the securities because it is likely that Wells Fargo will be the only broker-dealer that is willing to buy your securities
prior to maturity.&nbsp;&nbsp;Accordingly, an investor must be prepared to hold the securities until maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Securities On The
Pricing Date, Based On CGMI&rsquo;s Proprietary Pricing Models And Our Internal Funding Rate, Is Less Than The Public Offering Price.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference is attributable to certain costs
associated with selling, structuring and hedging the securities that are included in the public offering price.&nbsp;&nbsp;These costs
include (i) any selling concessions or other fees paid in connection with the offering of the securities, (ii) hedging and other costs
incurred by us and our affiliates in connection with the offering of the securities and (iii) the expected profit (which may be more or
less than actual profit) to CGMI or other of our affiliates and/or Wells Fargo or its affiliates in connection with hedging our obligations
under the securities.&nbsp;&nbsp;These costs adversely affect the economic terms of the securities because, if they were lower, the economic
terms of the securities would be more favorable to you.&nbsp;&nbsp;The economic terms of the securities are also likely to be adversely
affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities.&nbsp;&nbsp;See &ldquo;The</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated Value Of The Securities Would Be Lower
If It Were Calculated Based On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Securities Was Determined
For Us By Our Affiliate Using Proprietary Pricing Models.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CGMI derived the estimated value disclosed on
the cover page of this pricing supplement from its proprietary pricing models.&nbsp;&nbsp;In doing so, it may have made discretionary
judgments about the inputs to its models, such as the volatility of the underlying, the dividend yields on the underlying and interest
rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s
interests may conflict with yours.&nbsp;&nbsp;Both the models and the inputs to the models may prove to be wrong and therefore not an
accurate reflection of the value of the securities.&nbsp;&nbsp;Moreover, the estimated value of the securities set forth on the cover
page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities for other purposes,
including for accounting purposes.&nbsp;&nbsp;You should not invest in the securities because of the estimated value of the securities.&nbsp;&nbsp;Instead,
you should be willing to hold the securities to maturity irrespective of the initial estimated value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Securities Would
Be Lower If It Were Calculated Based On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated value of the securities included
in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we are willing to borrow funds
through the issuance of the securities. We expect that our internal funding rate is generally lower than Wells Fargo&rsquo;s determination
of the secondary market rate with respect to us, which is the rate that we expect Wells Fargo will use in determining the value of the
securities for purposes of any purchases of the securities from you in the secondary market.&nbsp;&nbsp;If the estimated value included
in this pricing supplement were based on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, rather than
our internal funding rate, it would likely be lower.&nbsp;&nbsp;We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences.&nbsp;&nbsp;Our internal funding rate is not an interest rate that is payable on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because there is not an active market for traded
instruments referencing our outstanding debt obligations, Wells Fargo may determine the secondary market rate with respect to us for purposes
of any purchase of the securities from you in the secondary market based on the market price of traded instruments referencing the debt
obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject to adjustments
that Wells Fargo may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Securities Is Not
An Indication Of The Price, If Any, At Which Any Person May Be Willing To Buy The Securities From You In The Secondary Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such secondary market price will fluctuate
over the term of the securities based on the market and other factors described in the next risk factor.&nbsp;&nbsp;Moreover, unlike the
estimated value included in this pricing supplement, we expect that any value of the securities determined for purposes of a secondary
market transaction will be based on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, which will likely
result in a lower value for the securities than if our internal funding rate were used.&nbsp;&nbsp;In addition, we expect that any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and may be reduced by the expected cost of unwinding related hedging
transactions.&nbsp;&nbsp;As a result, it is likely that any secondary market price for the securities will be less than the public offering
price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Value Of The Securities Prior To Maturity
Will Fluctuate Based On Many Unpredictable Factors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of your securities prior to maturity
will fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying, dividend yields on
the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness, as reflected
in our secondary market rate, among other factors described under &ldquo;Risk Factors&mdash;General Risk Factors Relating To All Securities&mdash;
The Value Of Your Securities Prior To Maturity Will Fluctuate Based On Many Unpredictable Factors&rdquo; in the accompanying product supplement.&nbsp;&nbsp;Changes
in the closing value of the underlying may not result in a comparable change in the value of your securities. You should understand that
the value of your securities at any time prior to maturity may be significantly less than the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We Have Been Advised That, Immediately Following
Issuance, Any Secondary Market Bid Price Provided By Wells Fargo, And The Value That Will Be Indicated On Any Brokerage Account Statements
Prepared By Wells Fargo Or Its Affiliates, Will Reflect A Temporary Upward Adjustment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of this temporary upward adjustment
will steadily decline to zero over the temporary adjustment period.&nbsp;&nbsp;See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Offering Of The Securities Is Not A Recommendation
Of The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fact that we are offering the securities does
not mean that we or Wells Fargo or its affiliates believe that investing in an instrument linked to the underlying is likely to achieve
favorable returns. In fact, as we and Wells Fargo and its affiliates are each part of respective global financial institutions, our affiliates
and affiliates of Wells Fargo may have positions (including short positions) in the underlying or in instruments related to the underlying,
and may publish research or express opinions, that in each case are inconsistent with an investment linked to the underlying. These and
other activities of our affiliates or of Wells Fargo or its affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Closing Value Of The Underlying May Be
Adversely Affected By Our Or Our Affiliates&rsquo;, Or By Wells Fargo And Its Affiliates&rsquo;, Hedging And Other Trading Activities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have hedged our obligations under the securities
through CGMI or other of our affiliates and/or Wells Fargo or its affiliates, who have taken positions in the underlying or in financial
instruments related to the underlying and may adjust such positions during the term of the securities. Our affiliates and Wells Fargo
and its affiliates may also take positions in the underlying or in financial instruments related to the underlying on a regular basis
(taking long or short positions or both), for their accounts, for other accounts under their management or to facilitate transactions
on behalf of customers. These activities could affect the closing value of the underlying in a way that negatively affects the value of
and your return on the securities. They could also result in substantial returns for us or our affiliates or Wells Fargo and its affiliates
while the value of the securities declines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We And Our Affiliates And Wells Fargo And Its
Affiliates May Have Economic Interests That Are Adverse To Yours As A Result Of Our And Their Respective Business Activities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our affiliates and Wells Fargo and its affiliates
engage in business activities with a wide range of companies.&nbsp;&nbsp;These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services.&nbsp;&nbsp;These activities could involve or affect the
underlying in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns
for us or our affiliates or Wells Fargo or its affiliates while the value of the securities declines.&nbsp;&nbsp;In addition, in the course
of this business, we or our affiliates or Wells Fargo or its affiliates may acquire non-public information, which will not be disclosed
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Calculation Agent, Which Is An Affiliate
Of Ours, Will Make Important Determinations With Respect To The Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If certain events occur during the term of the
securities, such as market disruption events and other events with respect to the underlying, CGMI, as calculation agent, will be required
to make discretionary judgments that could significantly affect your return on the securities.&nbsp;&nbsp;In making these judgments, the
calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder of the securities.&nbsp;&nbsp;See
&ldquo;Risk Factors&mdash;General Risk Factors Relating To All Securities&mdash;The Calculation Agent, Which Is An Affiliate Of Ours,
Will Make Important Determinations With Respect To The Securities&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Securities Will Not Be Adjusted For All Events That Could Affect
The Value Of The Shares Of The Underlying Stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain events may occur during the term of the
securities that have a dilutive effect on the value of the shares of the underlying stock or otherwise adversely affect the market price
of such shares. The calculation agent will make certain adjustments for some of these events, as described under &ldquo;General Terms
of the Securities&rdquo; in the accompanying product supplement. However, an adjustment will not be made for all events that could have
a dilutive or adverse effect on such shares or their market price, such as ordinary dividends, partial tender offers or additional public
offerings of shares, and the adjustments that are made may not fully offset the dilutive or adverse effect of the particular event. Accordingly,
the occurrence of any event that has a dilutive or adverse effect on the shares of the underlying stock may adversely affect what you
receive at maturity or, if applicable, any other payment owed to you under the securities. Unlike an investor in the securities, a direct
holder of such shares may receive an offsetting benefit from any such event that may not be reflected in an adjustment to the terms of
the securities; therefore, you may experience dilution or adverse consequences in a circumstance in which a direct holder would not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If A Reorganization Event Occurs With Respect To The Underlying
Stock, The Calculation Agent May Make Adjustments To The Terms Of The Securities That Adversely Affect Your Return On The Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a reorganization event occurs with respect
to the underlying stock to which the securities are linked, the calculation agent will have discretion to make such adjustments to the
terms of the securities as the calculation agent determines appropriate to account for the economic effect on the securities of such event.
In such an event, the calculation agent may, but is not required to, select a successor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">stock to which the securities may become linked
thereafter. In any case, the adjustments made by the calculation agent to the terms of the securities may adversely affect the value of
and your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A Contingent Coupon Payment Date And The Stated
Maturity Date May Be Postponed If A Calculation Day is Postponed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A calculation day (including the final calculation
day) will be postponed for non-trading days and certain market disruption events. If such a postponement occurs, the related contingent
coupon payment date or maturity date, as applicable, will be postponed. For more information regarding adjustments to the calculation
days and payment dates and the circumstances that may result in a market disruption event, see the relevant sections of the accompanying
product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The U.S. Federal Tax Consequences Of An Investment
In The Securities Are Unclear.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no direct legal authority regarding the
proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as described in &ldquo;United States Federal Tax Considerations&rdquo; below.&nbsp;&nbsp;If the IRS were successful in
asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the securities might be
materially and adversely affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect
the U.S. federal tax treatment of the securities, possibly retroactively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. investors should note that persons having
withholding responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally at a
rate of 30%.&nbsp;&nbsp;To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read carefully the discussion under
&ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;General Risk Factors Relating to All Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult
your tax adviser regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Returns</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the securities are automatically redeemed:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the securities are automatically redeemed prior
to maturity, you will receive the stated principal amount of your securities <I>plus</I> the related contingent coupon payment on the
immediately following contingent coupon payment date. In the event the securities are automatically redeemed, your total return on the
securities will equal any contingent coupon payments received prior to such contingent coupon payment date and the contingent coupon payment
received on such contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the securities are not automatically redeemed:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">If the securities
are not automatically redeemed prior to maturity, the following table illustrates, for a range of hypothetical performance factors, the
hypothetical maturity payment amount payable at maturity per security (excluding the final contingent coupon payment, if any).&nbsp;&nbsp;The
performance factor is the closing value of the underlying on the final calculation day <I>divided by </I>the starting value</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: #688FCF 1pt solid; padding-left: 0.05in; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>Hypothetical performance factor</B></FONT></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; padding-left: 0.05in; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">175.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">160.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">150.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">59.99%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$599.90</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$500.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$400.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$300.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$250.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$0.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures do not take into account contingent
coupon payments, if any, received during the term of the securities. As evidenced above, in no event will you have a positive return based
on the maturity payment amount; any positive return will be based solely on the contingent coupon payments, if any, received during the
term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures are for purposes of illustration
only and may have been rounded for ease of analysis. If the securities are not automatically redeemed prior to maturity, the actual amount
you will receive at maturity will depend on the actual closing value of the underlying on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Examples</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The examples in the first section below illustrate
how to determine whether a contingent coupon will be paid and whether the securities will be automatically redeemed following a calculation
day that is also a potential autocall date.&nbsp;&nbsp;The examples in the second section below illustrate how to determine the maturity
payment amount on the securities if the securities are not automatically redeemed prior to maturity.&nbsp;&nbsp;The examples are solely
for illustrative purposes, do not show all possible outcomes and are not a prediction of any payment that may be made on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The examples below are based on the following
hypothetical values and do not reflect the actual starting value, coupon threshold value, downside threshold value or call threshold value.&nbsp;&nbsp;For
the actual starting value, coupon threshold value, downside threshold value and call threshold value, see &ldquo;Terms of the Securities&rdquo;
above.&nbsp;&nbsp;We have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding
of how the securities work.&nbsp;&nbsp;However, you should understand that the actual payments on the securities will be calculated based
on the actual starting value, coupon threshold value, downside threshold value and call threshold value, and not the hypothetical values
indicated below.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; border: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical
    starting value</B></FONT></TD>
    <TD STYLE="width: 69%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical
    coupon threshold value</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00 (60% of the hypothetical starting value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical
    downside threshold value</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00 (60% of the hypothetical starting value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical
    call threshold value</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif">$90.00 (90% of the hypothetical starting value)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Contingent Coupon Payments and any Payment upon Automatic Early Redemption Following a Calculation Day that is also a Potential Autocall
    Date</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The hypothetical examples below
illustrate how to determine whether a contingent coupon will be paid and whether the securities will be automatically redeemed following
a hypothetical calculation day that is also a potential autocall date, assuming that the closing value of the underlying on the hypothetical
calculation day is as indicated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 20%; border: Black 1pt solid; text-align: justify; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Hypothetical closing value of the underlying on hypothetical calculation day</B></FONT></TD>
    <TD STYLE="width: 32%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Hypothetical payment per security on related contingent coupon payment date</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Example
    1:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">$85.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$38.75<BR>
</B>(contingent coupon is paid; securities not redeemed)</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Example
    2:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">$45.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$0.00<BR>
</B>(no contingent coupon; securities not redeemed)</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Example
    3:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">$105.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 1pt; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$1,038.75</B><BR>
(contingent coupon is paid; securities redeemed)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 1: </B>On the hypothetical
calculation day, the closing value of the underlying is greater than the coupon threshold value but less than the call threshold value.&nbsp;&nbsp;As
a result, investors in the securities would receive the contingent coupon payment of $38.75 per security on the related contingent coupon
payment date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 2: </B>On the hypothetical
calculation day, the closing value of the underlying is less than the coupon threshold value.&nbsp;&nbsp;As a result, investors would
not receive any payment on the related contingent coupon payment date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Investors in the securities
will not receive a contingent coupon on the contingent coupon payment date following a calculation day if, on that calculation day, the
closing value of the underlying is less than the coupon threshold value.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 3: </B>On the hypothetical
calculation day, the closing value of the underlying is greater than both the coupon threshold value and the call threshold value.&nbsp;&nbsp;As
a result, the securities would be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to
$1,000 <I>plus</I> the related contingent coupon payment, for a total of $1,038.75 per security.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If the calculation day were
not also a potential autocall date, the securities would not be automatically redeemed on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Payments at Maturity</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The next hypothetical examples illustrate the
calculation of the maturity payment amount on the securities, assuming that the securities have not been earlier automatically redeemed
and that the closing value of the underlying on the final calculation day is as indicated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 21%; border: Black 1pt solid; text-align: justify; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Hypothetical closing value of the underlying on final calculation day</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>Hypothetical maturity payment amount per security</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Example
    4</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$110.00</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">(performance
factor =<BR>
$110.00 / $100.00 = 1.10)</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$1,038.75 </B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;Example
    5</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$40.00</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">(performance
factor =<BR>
$40.00 / $100.00 = 0.40)</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$400.00</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;Example
    6</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$0.00</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">(performance
factor =<BR>
$0.00 / $100.00 = 0.00)</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$0.00</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 4: </B>The closing
value of the underlying on the final calculation day is greater than the downside threshold value and the coupon threshold value.&nbsp;&nbsp;Accordingly,
at maturity, you would receive the stated principal amount of the securities <I>plus</I> the contingent coupon payment due at maturity,
for a total of $1,038.75 per security, but you would not participate in the appreciation of the underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 5: </B>The closing
value of the underlying on the final calculation day is less than the downside threshold value.&nbsp;&nbsp;Accordingly, at maturity, you
would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Maturity
payment amount = $1,000 &times; the performance factor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">= $1,000
&times; 0.40</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">= $400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In this scenario, because the
closing value of the underlying on the final calculation day is less than the downside threshold value, you would lose a significant portion
of your investment in the securities. In addition, because the closing value of the underlying is below the coupon threshold value, you
would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Example 6: </B>The closing
value of the underlying on the final calculation day is less than the downside threshold value.&nbsp;&nbsp;Accordingly, at maturity, you
would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Maturity
payment amount = $1,000 &times; the performance factor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">= $1,000
&times; 0.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">= $0</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In this scenario, because the
closing value of the underlying on the final calculation day is zero, you would lose your entire investment in the securities. In addition,
because the closing value of the underlying is below the coupon threshold value, you would not receive any contingent coupon payment at
maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>It is possible that the closing
value of the underlying will be less than the coupon threshold value on each calculation day and less than the downside threshold value
on the final calculation day, such that you will not receive any contingent coupon payments over the term of the securities and will receive
significantly less than the stated principal amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Intel
    Corporation</B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">Intel
Corporation designs, manufactures, and sells computer components and related products. The company&rsquo;s major products include microprocessors,
chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing,
and digital imaging products. The underlying shares of Intel Corporation are registered under the Securities Exchange Act of 1934, as
amended (the &ldquo;Exchange Act&rdquo;). Information provided to or filed with the SEC by Intel Corporation pursuant to the Exchange
Act can be located by reference to the SEC file number 000-06217 through the SEC&rsquo;s website at http://www.sec.gov. In addition,
information regarding Intel Corporation may be obtained from other sources including, but not limited to, press releases, newspaper articles
and other publicly disseminated documents. The underlying stock of Intel Corporation trades on the Nasdaq Global Select Market under
the ticker symbol &ldquo;INTC.&rdquo;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">We
have derived all information regarding Intel Corporation from publicly available information and have not independently verified any
information regarding Intel Corporation This pricing supplement relates only to the securities and not to Intel Corporation We make no
representation as to the performance of Intel Corporation over the term of the securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">The
securities represent obligations of Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. Intel Corporation is
not involved in any way in this offering and has no obligation relating to the securities or to holders of the securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white"><B>Historical
Information</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">The
closing value of Intel Corporation on October 31, 2025 was $39.99.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">The
graph below shows the closing value of Intel Corporation for each day such value was available from January 2, 2020 to October 31, 2025.
We obtained the closing values from Bloomberg L.P., without independent verification. If certain corporate transactions occurred during
the historical period shown below, including, but not limited to, spin-offs or mergers, then the closing values shown below for the period
prior to the occurrence of any such transaction have been adjusted by Bloomberg L.P. as if any such transaction had occurred prior to
the first day in the period shown below. You should not take historical closing values as an indication of future performance.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 11pt 0pt 13.5pt; text-align: center"><IMG SRC="image_002.gif" ALT="" STYLE="height: 312px; width: 588px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 11pt 0pt 13.5pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>United
    States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">You should
read carefully the discussion under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;General Risk Factors Relating to
All Securities&rdquo; in the accompanying product supplement and &ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Due to the
lack of any controlling legal authority, there is substantial uncertainty regarding the U.S. federal tax consequences of an investment
in the securities.&nbsp;&nbsp;In connection with any information reporting requirements we may have in respect of the securities under
applicable law, we intend (in the absence of an administrative determination or judicial ruling to the contrary) to treat the securities
for U.S. federal income tax purposes as prepaid forward contracts with associated coupon payments that will be treated as gross income
to you at the time received or accrued in accordance with your regular method of tax accounting.&nbsp;&nbsp;In the opinion of our counsel,
Davis Polk &amp; Wardwell LLP, which is based on current market conditions, this treatment of the securities is reasonable under current
law; however, our counsel has advised us that it is unable to conclude affirmatively that this treatment is more likely than not to be
upheld, and that alternative treatments are possible.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Assuming
this treatment of the securities is respected and subject to the discussion in &ldquo;United States Federal Tax Considerations&rdquo;
in the accompanying product supplement, the following U.S. federal income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the securities should be taxable as
ordinary income to you at the time received or accrued in accordance with your regular method of accounting for U.S. federal income tax
purposes.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement
at maturity), you should recognize capital gain or loss equal to the difference between the amount realized and your tax basis in the
security.&nbsp;&nbsp;For this purpose, the amount realized does not include any coupon paid on retirement and may not include sale proceeds
attributable to an accrued coupon, which may be treated as a coupon payment.&nbsp;&nbsp;Such gain or loss should be long-term capital
gain or loss if you held the security for more than one year .</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">We
do not plan to request a ruling from the IRS regarding the treatment of the securities. An alternative characterization of the securities
could materially and adversely affect the tax consequences of ownership and disposition of the securities, including the timing and character
of income recognized. In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S.
federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar financial instruments and have indicated that such
transactions may be the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes
to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should consult your tax adviser regarding possible alternative tax treatments of the securities and potential changes in
applicable law.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><B>Withholding
Tax on Non-U.S. Holders. </B>Because significant aspects of the tax treatment of the securities are uncertain, persons having withholding
responsibility in respect of the securities may withhold on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying
product supplement), generally at a rate of 30%. To the extent that we have (or an affiliate of ours has) withholding responsibility
in respect of the securities, we intend to so withhold.&nbsp;&nbsp;In order to claim an exemption from, or a reduction in, the 30% withholding,
you may need to comply with certification requirements to establish that you are not a U.S. person and are eligible for such an exemption
or reduction under an applicable tax treaty. You should consult your tax adviser regarding the tax treatment of the securities, including
the possibility of obtaining a refund of any amounts withheld and the certification requirement described above.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">As
discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying
product supplement, Section 871(m) of the Code and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;) generally
impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments
linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that include U.S. Underlying Equities.&nbsp;&nbsp;Section
871(m) generally applies to instruments that substantially replicate the economic performance of one or more U.S. Underlying Equities,
as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However, the regulations, as modified by an
IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based
on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities should not be treated
as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying Equity
and, therefore, should not be subject to withholding tax under Section 871(m).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="background-color: white">A
determination that the securities are not subject to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover,
Section 871(m) is complex and its application may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You
should consult your tax adviser regarding the potential application of Section 871(m) to the securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">We will
not be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><B>You should
read the section entitled &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The
preceding discussion, when read in combination with that section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding
the material U.S. federal tax consequences of owning and disposing of the securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><B>You should
also consult your tax adviser regarding all aspects of the U.S. federal income and estate tax consequences of an investment in the securities
and any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: #0070C0; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Supplemental
    Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Pursuant
to the terms of the Amended and Restated Global Selling Agency Agreement, dated April 7, 2017, CGMI, acting as principal, will purchase
the securities from Citigroup Global Markets Holdings Inc. CGMI, as the lead agent for the offering, has agreed to sell the securities
to Wells Fargo, as agent.&nbsp;&nbsp;Wells Fargo will receive an underwriting discount and commission of 2.325% ($23.25) for each security
it sells.&nbsp;&nbsp;Wells Fargo may pay selected dealers, which may include WFA, a fixed selling commission of 1.75% ($17.50) for each
security they sell.&nbsp;&nbsp;In addition to the selling commission allowed to WFA, Wells Fargo may pay $0.75 per security of the underwriting
discount and commission to WFA as a distribution expense fee for each security sold by WFA.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">In addition,
in respect of certain securities sold in this offering, CGMI may pay a fee of up to $3.00 per security to selected securities dealers
in consideration for marketing and other services in connection with the distribution of the securities to other securities dealers.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">For the
avoidance of doubt, the fees and selling concessions described in this pricing supplement will not be rebated if the securities are automatically
redeemed prior to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Valuation
    of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">CGMI calculated
the estimated value of the securities set forth on the cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s
proprietary pricing models generated an estimated value for the securities by estimating the value of a hypothetical package of financial
instruments that would replicate the payout on the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;)
and one or more derivative instruments underlying the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI
calculated the estimated value of the bond component using a discount rate based on our internal funding rate. CGMI calculated the estimated
value of the derivative component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments
that constitute the derivative component based on various inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The
Value Of The Securities Prior To Maturity Will Fluctuate Based On Many Unpredictable Factors&rdquo; in this pricing supplement, but not
including our or Citigroup Inc.&rsquo;s creditworthiness. These inputs may be market-observable or may be based on assumptions made by
CGMI in its discretionary judgment.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">We have
been advised that, for a period of approximately three months following issuance of the securities, the price, if any, at which Wells
Fargo would be willing to buy the securities from investors, and the value that will be indicated for the securities on any brokerage
account statements prepared by Wells Fargo or its affiliates, will reflect a temporary upward adjustment from the price or value that
would otherwise be determined.&nbsp;&nbsp;This temporary upward adjustment represents a portion of the costs associated with selling,
structuring and hedging the securities that are included in the public offering price of the securities.&nbsp;&nbsp;The amount of this
temporary upward adjustment will decline to zero on a straight-line basis over the three-month temporary adjustment period.&nbsp;&nbsp;However,
Wells Fargo is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary Risk Factors&mdash;The Securities
Will Not Be Listed On Any Securities Exchange And You May Not Be Able To Sell Them Prior To Maturity.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Validity
    of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">In the opinion
of Davis Polk &amp; Wardwell LLP, as special products counsel to Citigroup Global Markets Holdings Inc., when the securities offered
by this pricing supplement have been executed and issued by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant
to the indenture, and delivered against payment therefor, such securities and the related guarantee of Citigroup Inc. will be valid and
binding obligations of Citigroup Global Markets Holdings Inc. and Citigroup Inc., respectively, enforceable in accordance with their
respective terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, concepts
of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing
and the lack of bad faith), provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer
or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date of this pricing supplement
and is limited to the laws of the State of New York, except that such counsel expresses no opinion as to the application of state securities
or Blue Sky laws to the securities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">In giving
this opinion, Davis Polk &amp; Wardwell LLP has assumed the legal conclusions expressed in the opinions set forth below of Alexia Breuvart,
Secretary and General Counsel of Citigroup Global Markets Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 86%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Auto-Callable with Contingent Coupon and Contingent Downside</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to Intel Corporation due November 2, 2028</B></P></TD><TD STYLE="width: 14%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Securities
Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition, this opinion is subject to the assumptions set forth in the letter of Davis
Polk &amp; Wardwell LLP dated February 14, 2024, which has been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup
Inc. on February 14, 2024, that the indenture has been duly authorized, executed and delivered by, and is a valid, binding and enforceable
agreement of, the trustee and that none of the terms of the securities nor the issuance and delivery of the securities and the related
guarantee, nor the compliance by Citigroup Global Markets Holdings Inc. and Citigroup Inc. with the terms of the securities and the related
guarantee respectively, will result in a violation of any provision of any instrument or agreement then binding upon Citigroup Global
Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction imposed by any court or governmental body having jurisdiction
over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">In the opinion
of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered
by this pricing supplement have been duly established under the indenture and the Board of Directors (or a duly authorized committee
thereof) of Citigroup Global Markets Holdings Inc. has duly authorized the issuance and sale of such securities and such authorization
has not been modified or rescinded; (ii) Citigroup Global Markets Holdings Inc. is validly existing and in good standing under the laws
of the State of New York; (iii) the indenture has been duly authorized, executed and delivered by Citigroup Global Markets Holdings Inc.;
and (iv) the execution and delivery of such indenture and of the securities offered by this pricing supplement by Citigroup Global Markets
Holdings Inc., and the performance by Citigroup Global Markets Holdings Inc. of its obligations thereunder, are within its corporate
powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents. This opinion is given as of
the date of this pricing supplement and is limited to the laws of the State of New York.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Alexia Breuvart,
or other internal attorneys with whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise
identified to her satisfaction, of such corporate records of Citigroup Global Markets Holdings Inc., certificates or documents as she
has deemed appropriate as a basis for the opinions expressed above. In such examination, she or such persons has assumed the legal capacity
of all natural persons, the genuineness of all signatures (other than those of officers of Citigroup Global Markets Holdings Inc.), the
authenticity of all documents submitted to her or such persons as originals, the conformity to original documents of all documents submitted
to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">In the opinion
of Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a
duly authorized committee thereof) of Citigroup Inc. has duly authorized the guarantee of such securities by Citigroup Inc. and such
authorization has not been modified or rescinded; (ii) Citigroup Inc. is validly existing and in good standing under the laws of the
State of Delaware; (iii) the indenture has been duly authorized, executed and delivered by Citigroup Inc.; and (iv) the execution and
delivery of such indenture, and the performance by Citigroup Inc. of its obligations thereunder, are within its corporate powers and
do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This opinion is given as of
the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">Karen Wang,
or other internal attorneys with whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise
identified to her satisfaction, of such corporate records of Citigroup Inc., certificates or documents as she has deemed appropriate
as a basis for the opinions expressed above. In such examination, she or such persons has assumed the legal capacity of all natural persons,
the genuineness of all signatures (other than those of officers of Citigroup Inc.), the authenticity of all documents submitted to her
or such persons as originals, the conformity to original documents of all documents submitted to her or such persons as certified or
photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&copy; 2025
Citigroup Global Markets Inc. All rights reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or
its affiliates and are used and registered throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.5pt 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236924_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">4,820</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">4,820,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">665.64</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">4,820,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">665.64</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">665.64</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">4,820,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  W %$# 2(  A$! Q$!_\0
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BHKE&%%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" $* CT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBJ.L7IT_399E^_C:GU-"U!NQ5U;Q#!IK&*-?.G[J#POU-8,GBK478E
M6B0>@3/\ZQV8LQ9B2Q.23WI*W4$CG<VS6_X2?4_^>R?]^Q1_PD^I_P#/9/\
MOV*R:*?*A<S[FM_PD^I_\]D_[]BC_A)]3_Y[)_W[%9-%'*@YGW-;_A)]3_Y[
M)_W[%'_"3ZG_ ,]D_P"_8K)HHY4',^YK?\)/J?\ SV3_ +]BC_A)]3_Y[)_W
M[%9-%'*@YGW-;_A)]3_Y[)_W[%'_  D^I_\ /9/^_8K)HHY4',^YK?\ "3ZG
M_P ]D_[]BC_A)]3_ .>R?]^Q6311RH.9]S6_X2?4_P#GLG_?L4?\)/J?_/9/
M^_8K)HHY4',^YK?\)/J?_/9/^_8H_P"$GU/_ )[)_P!^Q6311RH.9]S6_P"$
MGU/_ )[)_P!^Q1_PD^I_\]D_[]BLFBCE0<S[FM_PD^I_\]D_[]BC_A)]3_Y[
M)_W[%9-%'*@YGW-8>)]3_P">J'_MF*T+'Q<V\+?1#:?XX^WU%<S12<4-3:/3
M(Y4FC62-@R,,@CH:?7*>$K]EF>R<Y1AO3V/<5U=8R5F;Q=U<****0PHHHH *
M**KWLQAMSM^\W I-V5P&7%^L1*H-S#KZ"JAU"<G@J/PJK16#FV,L_;[C^\/^
M^:/M]Q_>'_?-5J*7,^X%G[?<?WA_WS1]ON/[P_[YJM11S/N!9^WW']X?]\T?
M;[C^\/\ OFJU%',^X%G[?<?WA_WS1]ON/[P_[YJM11S/N!9^WW']X?\ ?-'V
M^X_O#_OFJU%',^X%G[?<?WA_WS1]ON/[P_[YJM11S/N!9^WW']X?]\T?;[C^
M\/\ OFJU%',^X%G[?<?WA_WS1]ON/[P_[YJM11S/N!9^WW']X?\ ?-'V^X_O
M#_OFJU%',^X%G[?<?WA_WS1]ON/[P_[YJM11S/N!9^WW']X?]\T?;[C^\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS07,3[/-_P \G_[YH^SS?\\G_P"^:VZ*/9H+F)]GF_YY/_WS1]GF_P">3_\
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M/7\ZT+'6;'49I(K2?S'C&2-I&1DC*DCYAD$9&16=)X3@>Z@N/M,JR0WS7@(
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M **** "H+S_CRG_ZYM_*IZAO/^/*?_KFW\J$#(]-_P"09:_]<E_E5JJNF?\
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MI#'T4SSH_P#GHG_?0H\Z/_GHG_?0H ?13/.C_P">B?\ ?0H\Z/\ YZ)_WT*
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M3D\^]1Q0:1IDDD\2V=LS ;Y RKP>1DYZ'DT 9]QXI-O>R6OV/=*DAB^_QO+
M1CI_$,G\*HG5[SSD"7,P4[0=Q!)_TID/8?PC'TKHF73&FC=_LAEN'66,EES*
MRC"LOJ0.A%-B@TJ:5HX5LY)$ZJA4LOS%N0.GS9/UH KZUK,VF7(B@MHY0+>2
MY=GD*X5",@8!R3FJUWXBF43M;V\8BW/!%(S_ #>:(O,!*X^[^/Z5J3?V?<W1
MAF:UDN-C1F-F4OL/+#'7!XS3((M)FN?M5N+.2<_N?,1E8GC[O'? _*@"LVJW
M5IX534KJ&*2X\E'*(Q"MNQCDCCKZ5&^OW$.K?89++?Y3(MP\.]@A<$@@[<8
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MPGG/'&1TJ]8ZLE]97%ZB'[)&6\IP<F15&2<=N<C\*9I]QIEZ\AM1%'/!),N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* +Q\,NTDA$L0\RYEE8A3N*O%Y8&>Y'6K3:3/+X8&F2M"DRQ*FZ/)0E2,9R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" $* ?4# 2(  A$! Q$!_\0
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MWYT<\0+]%4/[47_GDWYT?VHO_/)OSHYX@7Z*H?VHO_/)OSH_M1?^>3?G1SQ
MOT50_M1?^>3?G1_:B_\ /)OSHYX@7Z*H?VHO_/)OSH_M1?\ GDWYT<\0+]%4
M/[47_GDWYU+%J$4AP<H3Z]*.= 6J***H HHHH **** "BBB@ HHHH **** "
MHKF86UM+,W2-2WY5+5'6O^0+=_\ 7(TUN)['!W%Q)=W#SS'+N<G_  J*BBN@
MY@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH V/#-^]KJ:PDGRI_E(]^QKMZ\[TG_D+V?_ %V7^=>B5C4W-J;T
M"BBBH- HHHH *QKN<SS$Y^53@"M@]#6#651C0E%%%9 %%%% !1110 4444 %
M%%% !1110 4444 :6G3EU,;')7D?2KU96F_\?)_W36K6\'=""BBBK **** "
MBBB@ HHHH **** "J.M_\@6[_P"N1J]5'6_^0+=_]<C36XGL>?5=@MX9;!6?
M".TXC,K,<*",YQ5*K$5S<) 5C/[J-A(?D!P>@).*W9SH6\M1:R*O[S:PSE@.
M1[$$@U=GLK.(WB@R!8GC56QDC/8<U0NFFWJEQP54;5   !YZ#BB2]GF#!Y,A
ML;N!SCIFC4+HMG25CW>=<(G[QD4D@ [>YR<^G3-5+>W62&6:5F6.+ .T9))/
M J=Y[Y$,CMD.?,^8*2,_Q8[9JK#</ 6,; !A@@@$'Z@T:AH7I;.#['%.&*Q+
M&6=@OS.2Y XS37TL(LW[TN\>3MC )VXR"03GG/;.*B6YNW1I@^Y(QM8D @!C
MG&/K4?VZ?YOWG+$DL0-W/7GJ*6H]"ZVEQ"10TK+OD2-0JYY*@Y.3[U$--548
M22L)1"TP4+E< XZYZU%'<7=S*JQN7=6\P#C@J.OX 4]=3*VCQ89G="A9B, $
MY..,_KBC4-!MI8F\0E'^=756&.BG^+\*D&G*UL\JR-\J&1=P W*#C@9S^.,5
M7MGN(_.:W8C$9$A']WO_ $IT5U<M$8(F++L*X"@G;U(SUQ3U%H7+G3(S?A(V
M\M)+@Q!0,[0 #G]:@ET]8;;>\ZB78) A(Y![=<YQ[4P:A>1-YOFD%SO#%0>>
MF1Z5$;R8P^47!7&T9 SC.<9ZXI:AH36MBMQ'&7E*&:3RHP%SSCO[<BEOXH8(
M+9(UP[1AW;')//?-00W<UNA6.3:,YZ X/3(]#27!F!C6X)RJ#:#C[IY'\Z?4
M-+&C)9V<;7:_O-L<"/DC)4G;TY]^],.D*CMYMPJ)O"*QP.P.3D^XZ53>]GD0
MHTF0RA#P,D#H"?P%*-0N 6)ESN()W*#R!@'D>E*S'="16_F)<MOQY*;^/XN0
M/ZU;_LR-3^\G<#?&@VIGEESZ]JHQ7$D+LT;8+ AL@$$'U!I[WT\AW/*22P?H
M.H& ?P%/46A<@T^*)BMP2[M%*RJ!P-N1G.?44#2$$L<+7*B4LJLO!Z^@SGCW
MJM]MNUBR7.R3<-Q4<Y^\ <>]-&H7 VD2\KC#;1GCISC-+4=T6TL8)[>)8F8.
M\KH'9>6(4$#KT)HBTE6Q&TF)2T:MQ]PMGCKVXJI!/(I1B&>*%_.*CC!XYSV[
M4^6ZNX+EV9RDDC"8C@\]0?UHU#0D_L^-HA,LKF$([,2GS?*0.!GOD5%-9;+V
M.WC?=Y@0J6&/O#O^=);WS185V9HP& 52!][KU!S]#3;N[:ZNO/QM( "X/3 P
M*>HM"TFF1R'*3MY8+JQ*<Y49X&>AJK<P+ 8BC%DEC#J6&#^/Y4K:A<.VXR\@
M,. !UZ_G43RO(J!FR$7:OL/2C4'8L:3_ ,A>S_Z[+_.O0V;:I8YP!G@9->>:
M3_R%[/\ Z[+_ #KT2LZFYK3V*$&MV%S]D\BX#_:T:2$!3RJ_>)X^7'3G'/'6
MI_M]I]G^T?:H/(SCS/,&W/IGI7.3^%9W7Q&+?9"VH%?L[ASPNT%U_P!D,^[.
M/[Q-4G\-79M"\=C<1W/G^8I-W$^T[-N=I381C@C&>]9FAVZL&4,I!!&01WI:
MKV$4L&GV\5QY7G)&JOY2[4W <[1V%6* $/0U@5OGH:P*RJ]!H**HW^KP:9/&
MMX#%#(C,LY^[N49V>N2.1ZXIL6MVS-#'/OM[B4+F)U)\LM]U68?*I/H365@-
M"BJL6IVDY@$<P8W!=8N#\Q3[WY4D^JV5M,T4UPJ2*\:$$'J^0@_'!_*@"W16
M3=>(;>)6, $VTIT;'WI?+/;L<_7%6;+4TN=-EO)5\F.)Y5;G. C$$_\ CN:+
M 7:*SO[?T_R$F\V3RW4N&\A_N\?/T^[R/FZ>]2G5[);EH//RR?>8*Q1>-V"^
M-H..>M%@+E%9_P#;MFP38[$M(D>UT9&&X$J<$9(.#C'6G_VQ8>3'+]H7RY(?
M/0X/*9 ST]2!CKFBP%VBH+6]@O(GDA9B$8JX9"K*1U!4@$55@\0:;<QM)'<_
M(L?F[F1E#)G&5R/F&>.,\T6 T:*SVUZP54+2N&>0Q+'Y+^9O R5V8W9QSTZ5
MH Y ([T 6]-_X^C_ +IK5K*TW_CZ/^Z:U:WI["844458!1110 4444 %%%%
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MK< 1F8Q$98;>">?7@4 K[CUO84FM$9QY2[_, ' ;<=I/KVIR7<>_<TT2R!5
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M@.SZ>GX4^BB@ HHHH MZ;_Q]'_=-:M96F_\ 'T?]TUJUO3V$PHHHJP"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:,%<^N/7FIJ* &&")M^Z*,[U"ME1\P'0'U%!MX6W;HHSN #94<XZ9^G:GT4
M0?8+3S7E^RV_FOG>_E+N;/!R<<T]K:!U97AB964(P* @J.@/M[5)10!6;3;%
MXHXFLK9HX\[$,*D)GK@8XJPR*[*656*'*DC.T^H]*6B@"&.QM(I'DCM8$=\[
MF6-06SUR<<YIJZ=9)&B)9VRHC^8JB)0%;^\!C@^]6** (196JF4K;0 S',F(
MQ\_^]Z_C4U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ;&E_\>G_  (U<JGI
M?_'I_P "-7*T6Q(4444P"BBB@#%U+_C];Z"JK*64JK%21@,!DCWYJUJ7_'ZW
MT%5'02(R-G##!P<?K6;W*.;LM<U'^S;#Y(;FXGLY;N224^6 $(^4!1WS5[5=
M3N5T"WOM/\M9)W@P)>0%=E!''UJW;Z-8VL<<<-LJI'&T*#<QPC?>7D]#BGM:
M6=S:-8-$KP1A4,7/R@8*\]>,"@#(35;^VU2\6X2&2V2[@MR YS&751\@QR-Q
MSSZTQ/$=PD5HTD,:Q3%@UQ-N";A(RA=RK@' S\V!R*VAI=H%9?LX.Z1)&R22
M73&TDD]1@?E4":1ILRJT<"LB$J &8+D,205S@_,2>0: 'W][/#>6]G9Q1/<3
MJ[@S,5553&>@)SR*HMK\T>K16KV\<D3S>06A+DI)LW8+%=N<@C&<]#6I=Z?;
MZ@$6YBWE22I#%2">#@@@U2M--TB]$5];0*XW%HVRP&X#:3M)QG QG&:0&>GB
MJ8Q!9+5%NWE6);8+)OC)!/SKMR< 'E<@FMO3;J6\L4FN+9[:4DJT;@CH<9 .
M#@]1FHAH6GB%HOLN5;;DL[,PV_=PQ.1CM@TZ+2;:"ZAGC5P8$=(U+%@"QRS9
M/))QW-,"K?ZVUCJ)LC K3S"/[(-V/.+-M8'TV]3[56F\2RPVK79M8S;R+/Y&
M'.\F($G<,8 .T].E:D^G)<:K:7LA!-HK^6NWD,V 6S]!C'O0ND6*3R3+:IOE
M#!LY((;[V!T&>^!S0 VUU W&HS6IC"B."*;=GKOW<8]L5E7/BPVD\T4EJ,P-
M*DAW\!A_JAT_CY^E:MA8:?8SSK8HBS (LH#LS 8RH.2>Q.*=+I-C.TS2VL;M
M.Z22$C[[)]PGZ8H PK_6+WS9%61H6B>Z0A2.JP!AV[,:T+N[N$T;2Y4E99)I
MK57;NP9EW _7-7I-+LI7=Y+9&9V=F)SR77:Q_$<5(]G!)#%"\2F.%E:->RE?
MNG\,"@#(3Q#<O%',E@)5N899;6.)R9'V=F&."1SQ]*B'BB5TACMX(I[F4R?+
M$DI"! ,AEV[@V6'!'O6J-%T\-*1:J#,"K89NA.3CGY<GGC%(=%L&C5#;_=<R
M!_,??N(P3OSNZ<=:- &W&IO#HL=Z81#*X3$,^X$,Q VD*"2?8#FC2M3DU#3Y
MIGMV2:&22)HP"-Q7T# $9XZU8DL+:6S6T>(&!<;4R1C'3!SD$>N:+;3[6SMG
M@MX0D4A9G7).XGJ23SDT@,6'Q)++Y'G1QQ.;A8Y85W"2,%6)#*Z@_P /4<'L
M:)/$MU#:_:&LX"DEF+N%5E.2"ZJ%8XP#\V>*UH='L8"ICMQN1@ZL[LY! (')
M)/ )XZ<U0LO#%O;RRO<F.97B\D1HC(H7=NZ%CW X&!QTIZ ,FUN[CN/LSQ0I
M<)<>2VQB48&%I%/(SVP:I:?KEY:6=J;HFYFN;2.=09,J7=PH&2,@<]N!71/I
MUI).9G@0R%Q(6YSN"E<_]\DBF'2+!HA&;6,HL(MP.>(P<A?S&?6@#.U;7;W2
M(B9K>VEECB::6.$R,=@/487@8[M@9IYUVX^W.@MH?LRW:6F\R'>6=00V,8P"
M0#S5F3P_IDT7ERVN]2I5MTCDL"<D,<Y89['-6?[.M,D^0F3,LYZ_ZQ0 &^HP
M* *GA^[O+W1(;J_\DR."08L\@$CD$>W:L^/Q1<+9P7%U91+]JMO/@6.0GG<J
M[6)''+ Y'O6Y:V-O91/':Q^4CDL5#$@$]< GCZ#BJ6F^';'3]/%J8Q.3"(9'
MD).]?3!)VC/.!0! ^M7BWJV'V6W-Y]H\ESYC>6!Y>\,#C/3C%06VLZ@L*R7O
MD%&U%[8&'.=HW9R"/]GMS6Q#I=G;^68H &C<R*Q8LVXC!)).2<<<TBZ59+.T
MPMU#M*)C\QQYG][&< \F@#)D\37$-F)Y+.(F:W%S;JLIY4NJX<XX/S@\<=:U
M-.O9KF6\@N8XTFM91&WE,2K94,",@'O2)HFG1I(JVB;9  P))& VX <\#/.!
M@4Z?2K:XG65D(83K<. >)'484M]/Z4 5]:U673%C%O'%+*RN_EL'+$*,G 4'
MCU)X'%5%\232;IH[2/[+']FWEI#O_? 8P,8XSZ\UK7NFVFH;?M<(D*@@'<5.
M#U&01D'TZ4U=)L5B>);9!&_E[EYYV8V?E@4 9D6JW=YJ^G,GEQV,TMP@ 8EY
M-BD988P.1GBIM3UJYLKF[6&UADAL[=+B5GD(9E)((4 8SQGFKD>D6,5Z+N.V
M5;@,S!MQ^4M]X@9P,]\#FHIM#MKK5I+VY!EW1)&(B2%&TDY(!PW7H1VH KC7
MIFE5UM%:UDN)+:+:Y\UI$!/(QC!*D=?2JR^);EK)Y?LL7F1N%F4++FW!!),B
M[=W48! (.:USI-BUS)<&V4RR;MQR<'<,,<9P"1P2!FHQH>GA-H@898-N$TF[
M(&!\V[.,=LXH R9M:O+B>%;-XB6N+8#:^8W#HQ(SC.W(^OTI'U^\^U&58-QM
M[>X\ZV5_E9HY%!93C/W22/RK8?1-.>/8;5%7*$;"5P4!"X((Q@$T]-,MH$'V
M6)(I$B:*-\%MH8Y/?GG!.>M #=,U--32>>$+]D239%,#_K0 -S?3.1^%85QX
MEN9[6X146)_*2>*>'?M9?-5#@LHSUZCBNATZPATS3;>Q@ \J",(..OJ<>_/Y
MU!'H&F1;MMFOS((SEF/R@A@HR> " <"@!='GEN(;IIG+E+R:-2>RAL ?A4.I
M:Q-9SW"6]O'(MI;BYG+N5.PDC"\<G"D\\=*LC2K87D-PJE3$TDBJ#\N]_O,?
M?K^9IUWIEG?2))=6ZR,@P"21D9S@X/(SV.12 I:)/=WFHZE-<2YA2X,,*!SA
M5VJ1\N,9YZ^YK/M]3UBXBTUBUL9)[^6$ $JK*OF##<=MHZ>E='#;Q0-*T2!#
M*YD<C^)C@9_05!%I5E#,)8[<*XE,P.XX5SG+ 9P,Y/3UI@8Y\4W$B1+:Z>TU
MQY)EEC17<<.4VJ54]2IY.!TK3U;4I=/L8[B&V9]S#>65B(EQDLP4%O;@=33I
M-$TZ1$5K8 1A@I1V4@,<L,@@X)YQTJ>YL;>[C1)D)6,Y7:[(5XQU4@]* ,2#
M7;QIM0G:2P-E!;Q2HP=L98'HP'()'UI@U_4;JZMK>""&&87OV>995=0RF(N,
M C</R[5KMHFG/D&T3!B$) ) *#H" <''8]12#0M.$;(+;AI!*6\Q]V\# ;=G
M.<<=: ,Y/%,A6:X-A,;&,2_O51QC9D<DC;R00,'CBK.EW5_+K5]%?&)0D$#I
M'$Q*KNW9Y(!SP/RJV-'L!-)*+9=TF[>-S;3N&&.W.W)'4XIUEI=GIS2-:0^6
MT@578LS$A>@R2>F30!:HHHI %%%% !1110!L:7_QZ?\  C5RJ>E_\>G_  (U
M<K1;$A1113 **** ,?4U(N\]F45E:F<:1?$'!%M)S_P UTE[:_:8OE^^O(K%
M92I*NN#T((K-JS*1Q=KI$UWIUNUK92P6TD=H)(V8 S%7#._#'^'N3DU?ET.2
M35MOV4?V?]MBDV @)Y8A*GY<]-Q'%=(  , 8 ["BBX'+6^E7$(MUO].DO+:)
M98XH%93Y1\TE6P2!C9@ ]1BJDUE(NHQVUY8RW;R0WK)$K XW2C8Q)(QP1SU%
M=I1@9S@9Z9QS1<#DQI6IKJME))"6F@FM]US&J8=%4!RSD[LYR-H&"*T+6QN[
M?P<UI]G1[KRY (7/#98G!P?0^M;E%*X')6.A7+7$<=Q:R&Q%^DOERJB#9Y15
MB40X W8X[]:(-!O[>QMUM8C!=-!=1RR;^>2/*!.?08'I[5UM%.X',1:?<PSQ
MW-KI\UO:17$$@LP5W_*K!V W8_B7OSMS4<.AW-UL-]9DKY5V=DC@[6=\IT/7
M'Y5U=%%P.<TNQN-.O+F[GTUYKJ2UA(D0IEG6/#H6)X)(^A]:Z,'(!(P2.GI1
M12 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***GM
MK9[F3 &%'5J -+35*V8SW)-6Z:JA%"J, # IU:HD**** "BBB@ J*6WBF_UB
M ^_>I:* *?\ 9EOZ-_WU1_9EOZ/_ -]5<HI60%/^S+?T?_OJC^S+?T?_ +ZJ
MY119!<I_V9;^C_\ ?5']F6_H_P#WU5RBBR"Y3_LRW]'_ .^J/[,M_1_^^JN4
M4607*?\ 9EOZ/_WU1_9EOZ/_ -]5<HHL@N4_[,M_1_\ OJC^S+?T?_OJKE%%
MD%RG_9EOZ/\ ]]4?V9;^C_\ ?57**+(+E/\ LRW]'_[ZH_LRW]'_ .^JN446
M07*?]F6_H_\ WU1_9EOZ/_WU5RBBR"Y3_LRW]'_[ZH_LRW]'_P"^JN44607*
M?]F6_H__ 'U1_9EOZ/\ ]]5<HHL@N4_[,M_1_P#OJC^S+?T?_OJKE%%D%RG_
M &9;^C_]]4?V9;^C_P#?57**+(+E/^S+?T?_ +ZH_LRW]'_[ZJY119!<I_V9
M;^C_ /?5']F6_H__ 'U5RBBR"Y3_ +,M_1_^^J/[,M_1_P#OJKE%%D%RG_9E
MOZ/_ -]4?V9;^C_]]5<HHL@N4_[,M_1_^^J/[,M_1_\ OJKE%%D%RG_9EOZ/
M_P!]4?V9;^C_ /?57**+(+E/^S+?T?\ [ZH_LRW]'_[ZJY119!<I_P!F6_H_
M_?5']F6_H_\ WU5RBBR"Y3_LRW]'_P"^J/[,M_1_^^JN44607*?]F6_H_P#W
MU1_9EOZ/_P!]5<HHL@N4_P"S+?T?_OJC^S+?T?\ [ZJY119!<I_V9;^C_P#?
M5']F6_H__?57**+(+E/^S+?T?_OJC^S+?T?_ +ZJY119!<I_V9;^C_\ ?5']
MF6_H_P#WU5RBBR"Y573;=3G:3]35E55% 4  =A2T4[ %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=AEP*N 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MP)0"\$>39 D\0 "!"50XF6F.J6>:0!TX  %ZII634 +H.>GFFS\]  *54ZH
MCTT)<'B!<0]<L,\U[D#@@ 2.+5!!!.[<&: %UWRVI048?(;0>7!6:FE-77I
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M0(V.D4Q#6+=HA9RN,?<V-TX>!MFP-KIB1Y9*]$#P"S2_[0*G-LBLO-?GB6"
M0?(F3[/US1($0&!9FD49NY62H#X=R0 2\.!"P(<?7=9;(>O_H?B^>PBONC7L
MUS@9P#BZP8YNV/SF.,^YSL4Q /#TR3&GBX:01 0J:@N$'SM&E6*\!AYA&QL#
MURA'/@CP.764"HEG/(W?.EUT\ @IX2H/B3KW0=H)G#Q<&W?)!S; ]@VXP 5N
MA_O;XT[WN<.]!95>'F3@L8]IOB\!I;) %P?R&J'EB4..M(?JT/-5WWB@ <LB
MP (>(  )0  $%DBK&J\1X04?:$EA+PG;;O;#E#V;)A]H =S9WH(-M/[UKH\]
M[&'/GP9P5R#EH "#7A:EOC.NO!=0&A)98($.2-:0 )#-;4]G'&4VKP.GBD".
MKN/XOJ<H&@F8>.@Q,H#YPNL!9S]V_X=AL@YA),$;&3A_^C.0?O0G@?WJ?__Z
MNR&I]2I1@@"(Q@,&AX#$0N8U310<=V( [D 0?0(/N $/SP$9D$(>%0([KP4/
MZ-(]#;=]'($T^@)V*'-Z4-$G S$ +M4I2D(9J'->BC-Y930 2N(8\#  F209
M-K(C T$/#%))   "\#""V.0 CE%:%M@1#* K5.-23Y-V27$>*G -CH$$2A,E
MS8$B!E*"[L !]. .DG$!!U >H'(!'$  DH%Y$Z(Z!C,J*B ]H=$.VF4 Y8 B
M[H ![*$ZX_:##C$W^N)BAJ$?<3@3'.@478($IH4JY?0 "V!V*S,!< ,M$X !
M_%&(I+$R$O_@*2L&-E"2#ZVQ&(0X 8(8#XR1*V\&  N  1HHAQ A;&#5+-KG
M%Y#W#P^0AS !<Z)X*[LS9D9G&?TG=1X@0:S($D;XBBN"  S <F'EA9FQA61F
M ?F0'>&'$GO(BTTR1*25C'Q!>9UQ-?\  A"@$\O(C"OB(^;2:;3!'L.R %:H
M$ZZHC4SB(Y-C(XF5&0L 4<UCB#VQB^9('0OP"Q'##M.A*RP@&B @?#PAC_-(
M&R&#:%2B O\ C8%! "K@ :=18CV1C0$I'<HB R/C<K9QB#U1CA%9';.6;J9D
MB(\2*KV&$P"YD8>! 'M&)_*@?_,1*@NP*3^R$Q!IDNDT;'3B#J?_F!F2H1^3
M]P#E!(V[827PT"_P("@(,SR3,3SC,GXTB1C>%UD.($4.PD&AZ!!?-4]WPC%
M1A# (2IRXH, 4(T(IQ :V926X0! 0R=?E(LJY3N4,1&/! '[%P^C @(^ID%
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M_=9.X(=JX6,!^8F0">$C4IH?H(:D<K$\YA)=QE*/G,&0.2D159H?1XJE99$
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M$;"ZYWN__]-!G#:\OLL"@TMFD7N-#W$=9Z24H$&<#/ 9N-$:UQ!% O$/;X0
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MT5!!"LVK\R.H]ZUR#O#>*L!7$9#7>5O>%"=L2QH!["R8H*)&2BW?= K0TBG
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M0-$)%Y#>NX   (%K$"@4M9!O082B%QXP3?#5Z5JV;=V^A1M7[MRF_+ZQR*A
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M=[$41ISN9QU_GVZZ_ZE]\$S/MWUQ]O=>'7?<[X_ +V"E K-\SX '_-IT+$
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MMD$DFO1GIM392*%E/'Q"D7$$^"*L+K" Q)96EYX#@8X\0 #NO4NLIIU3 B+
M05*^SG^.NYI=G2@POM6U;@G5HC^/)\+/,K*<?(5M<N&8  PX ![E6.-AE5LI
M!"2NC^#L(%SUV$%H];.DG;T@%$GZSX$N,G2P@N=TU7M#PJKV@>_"!V+7.S,)
M&#*I3GW=7)%:TB1F\9G\95AF[?@[$JK#9A4PK@ HT(# SM?!:GN "D#0@0NL
MEE\,V.B#D=0 #S3 >-(LZ#X#>4%J/I%])99BZR(;Q< Q+FL#M$"#-3QC2LG8
M*0P@0 (0@ ";V=A20*4QD2  @B@--WY'%/]E<.M(O)7*;Z4J!K!<A]>\ 5(
M D'&LND<0&$*6*!L_'IMEKL##U)V<(7-])F*I:G9:_ZVI?)C(113_-MVC"6T
M9_J7F/6L-@Y[X$<JP![I]AP>!$P@B^;S[$E9:L1 !K2$ H4F^HC'/MQUD9R
MSNB@-;TR!VA5QVJ\<(8W39=[1( =)[8N4SM(-%7JS,F\Q2<I0[E9@VKJ&G=&
M$VE'O>N4/<#**@,RK^&2S*2.%-&(.]P)TXILS%J0OZL6BY\N4-,<"]O:^W(
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M"($0H $\,U7J(@ 3!%B):X#_-GV5#"5,QG. 3M '%W "7WA&B#(64HQ8?X,
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MB5H O)7V1$\GB:<D! "20MFY 9=E5JXNZ:".@MQ#"8@&V6K%U@-\>PY\6B:
M:02 ?[E'6B0*)-B'^(Y;#QAD$)"G)+[N:W@\K?B'YJ" L]@'<J_[ SIW..('
M!JB" 09UOI\3_VX_&1 @K4\&_+/X8P=8!QS&CF9YD1BC[@)\\C:N@'L(R39N
M_.I."@/@@** SQ==D8S$X=7_1J. 3Z- @K.&1<\1:PJ([[-PUM>WH=@G(X!3
M7MZ=<P"TN7A_DT1MXU]@!_MG[JW@ -R<Q^,'"  )+L!S ,#!!00-(B"@0 "
M 0\++DP  ."!10 $+ # MP\> 0, $'BH:,!  @L, 'C(!Z < PL/$8C+5\%B
M! /\/$@ ,(% 2HS[&F0L:O0HTJ1*ES)MZO0IU*A2IU*M:O4JUJQ:G=Z[L/4K
MV*\,.FU0T")#"Q<:$(2M^L!=V[@"/5RX .)! A 4+F"$" )!7HP15O\0(*"B
M\-X)^"ZH:/  1%T0#AY?L&#0(@8/].[>4^'!8#L/^^@E ! !Q((%=%7FW?L
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MKG[=Y?^P8J*+M4 !+O"&.,;:+XC^M;%.XFI2ID@6L!90L?XJIF,S^]B^]BF
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M'-TINQ<!( #!\R80#9P4]"C\0*\5DR!"]6V4S/O-"W @<A.-//% $CA)!A3
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M %R 05C !"P  91#$5IB&&X%$[+(!/D$!U19+U;$ W1@7*C&0^A(SJW+/6
M1\@?%3H%_K%$"QW=X0E/SJW$[AS',FK -4" TH% ;+%0<IS_A^8P(P XCIDE
M0!/=(G+PE5?D'%M80 ,TH /\!40TWU? X7=8&Q_I2"4N@!J&A0-XP$CX(@1P
M1$5Z#CZN&0-(P)/A%.F4!O;T(GQ472]F#[89$2Y*R03LV35P@$4$703T7$-
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M3%6*#E=:XN-9@,1>!6N&95Y^1R!1R./AI03VD2TF0 2(U9\>D470@^Z@75O
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M]\.:Y8-;JX $F-F)Z_]T_E@.5.><#QN?6SO "M"S"M3T1+KU$IVX"J1,<W9
M_0J$#+QT433 "OPX*X/ 33QG- 2O!PA )W8T](;Q!> R;V<$ SCP2#R/!:P
M!:A !-J%/0O 0 H M+UR09$P723$ OR"01^(!0@ "+2# <@#&/W"2D3$UFI(
MBCN0+T&B6U^ GFM$N*7Y G<X0Q/ "CR&![2# &CT/U! B(^T!\@ *TODD)?Y
M^^R&"N0#16O/9X!1+F=T71@TID=77F@T!;CUPK!R!OZZ4,IB1Z^+#&!Z@@2G
M/>!R< 8NIC^E6W? "@3XFD>[AKPY4&KG@]*YG?>B9 3GGHN5.YQ90<6#/+#_
M ,/@.OZZ@T'O]JE-[VF<<5#9LVCP=@00=1 "P HTAF.K %<JWV'PPR^4M0!T
MJP P2'L+!&*R@$ZS,@"4VX.B9P>\SZ%79D98C@/LPU\X0+;2N27R^6Y_M9XO
M@  DP&ZKO)Y:! CVXDBSLN!0-$;L=@.NP +<0VP[P)1WCENKS ="D$8G )^;
MHO!E]&DG?,FG-SM @ KT731H=-]@*Q&I]YIK1,JG..ZD/(E_1WH72J$?>E$L
M ,Z/? /&-CRH $H0=WJV.>%=A&=_(%<2!DNP +8)@&EP1)F#M9FQ0&<G".3-
M>>;H^36D?,DO@$ 7A5T(1(B.AP2L@'AH]$+'JPRP_VN;8ZH &+9!:(\0=5^P
MJ_=@E,9OS_/PT/-X9+2!4#1_Q#W.?SW/]UU&W^YE.,8\B\35S[/*:W1ZP[.(
MRNB@<D1ZXX4\%-2;N[?V ( Z?,8?*]<'XB4!6X \K#E#(#JVRH-<$CTNJP [
M$(#=%SY>K( #24 $;,XZ$,!GG%G._0)C=-T\TR9$)X1=#*8[X(9&=/_"?[UA
MX".BXS)ZL#H = ! >$! P4,"  <G"'@  (/"!3(:-!   H0'!P<3""AXD&.#
M%1(,"&"0D0""B@LK""AG0,6]AA @") @044#C@<E"(B A&,"=Q$$3 !PP0,
MH FN*4Q(%,0ZA H!"* P5/\  HX/A8:\ET_  GPJ**ZX>#!D!(PV_W5](&-"
M3 D +'B !Y2H!7@JBA[TH )  @\@\AV\H (! 17P.,B[)_&?@5]C 2#H< $!
M P$6#D8H^$">!(D+''R\)X# S:,)VP%PH(*"P9L('H 0@.]:/P8 X-D#6II
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M<D74('H P  W(M*$6,-  IX&PP%9D(UC=$T9W6&0&6+2C5BSA]T 4(XB\L0
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MEI$!-D0@B_$@$3(A#8R&)D ""("H%%*E($ &A#$B+?(B$9(!](@#_ \C+VH
M"LHC17(D2;(D3?(D43(E57(E6;(E7?(E83(F97(F:;(F;?(F<3(G=7(G>;(G
-??(G@3(HA;*I @( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=A3 (X 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M[#L_^]#7OO2W3WWN6[_[U]?<]K_'??!U/WS>[]I^\=:HN%5N%I"?O"N@X@S
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M6TZYKQB]IZWEDRRY8Q[;8'[FDVR)9'[;9LZ:>UJ.2%N:,&UV;[Y$.6>H\NV
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MW^\!#_4[S_,L_^]&?P](O_'VOO0[;^\K?_$VK_-23_%4K_)%W_58G_1;K_%
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MN4NQ+B(S,:0ZIV0KE J[2CNK,6P++0@EB10E6;2MK=$*KT2[U7@506.=5U%
MVDH88]K)(@%".S2^6[2<\JM%QX0X36JY&GHQ:ON,@@*2>:G*2IP^";,_OOLZ
M=$&]%_FT,G,@R/3*L//'SQ@Z@HNHJ3(]&%RU&G1(3](:V<-%1J2S8;NX"D.6
M__2K)?7IP]W11])[37Z[(5JSL[RDEF)$.V*[+[MLH72(H3$"*JXL,X&4FH?$
M'%M*#X,+P<QD*'!#'>B!E2*2/"(307(#02&;HG'SOA1$180;$::CNIK!IL@9
MN7_)&I(<0T#1&KJZK+&,R:@QPW9)O[5DPD[;P-LQ3^=JQ9^BKO R#[^0F[,I
MG$ B,L')279YL*X)D@W94#A#,["YD?)KNUVYA\623A?"2^YJ*W?Q'>5:30/B
MD(@QJ4O[JU%4(R?9N9!!*-E\*R/$,VH,MCW[N4&S0&PLDIFDM%T!$<1TQM]X
M1!#R'FM).+3#)_3QRK8,)",<JK?9-U[YGI]T+0=]Q_]7Z1CW,#AH)+MK0BW-
MPJTX#;0RV4L]*ZLXBK>TB5.*,9FY8 LH>;(,PJ?%*"[N])"(;-'8@2$'>9.^
M8J.X;"T7Z;G8:\8]LD? V9BVM!J_$<7'@RU(!3P8*U .K<I( U&/6C8.])K"
MN*JT<Y0$XS0QT2D*Z4>CF40>DLK7<\Z5.C*_\)6 $54MFB,8LY&K-%83#1I$
MI56/9!XU83A4<\VN$LEUTP["T4S,H<'J,#)*DQL>M4[TP!9P 9XZE<$C;3\6
MM<MK@(!\2 "HL"^J0(@%R <678 $, "H0(AV6+FXLLRN^ZH;M93P$!(8\[OZ
MX1SRXSXDH[%#D4^=NR.M=#G_5LO GQ+1VKJU9G$MS9RK&J'!KB*A&Y6@)ANH
M)S+1X[$U='U.>R&STT1$_VD@;#NU$_0>4L4RH@*M@!+7XEJNA(,@](F8*4/
M.>-0>)PKRMI-7W$6KWN5I %4O[!4[Y'2P<2C-ST\Z9PH#&@=!F@*?3T*(U"
MQ>):KJ6(1AVWO ,C]X(S<0/6ZH/:3 D]CU&7*!FF9N/$+4R9 2.^5?,C[U(]
M/D$]/ 4K,7%6"E2CSM"XO(RB,QI'#WHB<OI*7M72E!TGC$7;W?+(FSS6@X.?
M03H4DA-0;U7*D^H3*<I2'V&5<AG0/MJF'%4TK0)%X(A'W#(M+FG#W/BZ#*LA
M7>'5_REYQ1:]UP"8F:B@J 3@CP68"J5@@'W85P8PBIN WNB5WNFEWNJUWNO%
MWNS5WNU-B7T(WD4UB #( *A( (IB@,4" 'XP@(D @/$U"@; @ 50K/FEW_JU
MW_O%W_S5W_WEW_[UW_\%X  6X $FX (VX -&X 16X 5FX 9VX <>X 3P,KL\
M"JAP7W:@* A8+&TX7^6%BJ.(7P/0 @@F81(>X1)6X!-&X1468196+!5VX1B6
M80=>4?R%X1EV8.-=U 5 E:@XD/ -@.!5+&UXU^\-@'A@@'X 0^YEXB9VXB>&
MXBB6XBFF8I( !Y0#7GH@$ 5("J-8K 3( /=-APQ0 'G=K_]^\+4.<9PBFA.0
M<!$\#:0BFI)#^=PUMN,>LM4NT38\F=UIZH@]DT:":S1ANN,Y,60[1E+#39RV
MQ!0]9JU$AN0N <_N0QK7/&1 /F3JTR?G@$K,*:(]CN1U),P^/B,D])N/:+1(
M7A.[T#^0R&0?BV2GR8E%Y0E[: "*L <"H0B,R&6*"#,MV( -2(=88E:]*I;Y
M068)]-OY[!IX8Z/9,RWW*!G=H\/G:QYMT (,(URZ2F9MWK8IBD1^B:1XDN:<
MNS@:;+IDDHV.P15L#652KJ(VBZ5(>BZ!J;T5).98,A>>^PRQ>A&/NSC'2UO=
M$,F8Z[LNNK/>8=-4RMTQB8U(LZO_A>ZH7"0ZCY3+230 =Z#EV#F5 &B =+
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M#/*%/;@#T]E@ A@  #  \"P /8"#$20 #?82 _1#7AB $*1# T!-M&$&8A2
MV32%0V15V$R $1R-$C6 T*C5-3H$&G*#$>1')L4&6AW$.Y;_4CLFQ1*IU9+Y
M7*^(#78EQ4*(W1?%(\<%DCL>#C>BE3RZH\*AGT'"(T%Z15TA9&P(2"E)9#P6
MI$'*(T@4)$.B5;Y<9$4FY$$").48I$3FQ $Z9$6^CT5FI$>VI$K*(^G-XU P
M2EM0Y$'^$UJY%O],8(EY9$>N9%((3*]!)%$B25+DBTD6),WUXEX 0 8P@#$&
M0 8  ! 6552:@S&."  H %4&@!$(@0C(2&)$3B)H0 $\SSS$Q(><C]CPRA<B
M#Z^(0#IH00, 2V*8354(WSPL@-()P"<R2T4@FU\*@,%\"&#NI39\C4 8@5J)
MP#PQQC>.C;0)WR>N(14X0%I4AO"!_]>'A -?@@5?\B5X%:9*(%M%"-\\S9."
M'*8V!*9FEB9J+@"^()M**-T\?8VEM.9??J)?'B9ARF9:!N=IGJ;DA>9J7@-@
MBJ9H\H1R#F9OUB9?MN9>>J9@"M\UD.9R_B5A$B=UUB9S:J9@!B=OBH1L\J7!
M-"=KEB9X+N='4*9A)J?2(5MBKB=AUN8\#.9>_N9J>B=YLN8\("=P&J;!Z"=O
MMJ=?VN=A!N9_5B=MEB=A?HB!&NCH;69OIF5I,HOP02="G&<X).9^AB9/_.?J
M,27L5< "[ ,#+  _4&4"6"6M+( Q0D  ."55FD,&"$&:)88EI$,"N(,1L ,Z
M)(8(M(,1M/]#BQ*I.["E=0EI.[B#T:G5!%B"7*4ADJ:#.Z0#D6:I$<3#,":
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MBC0O0#F23==U'=$<"@!485NJ0]@\C^-,4JN 4J2@HFFQI6LHKZYXFSJ82I?
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MW<EUC^9M*IGM7X0<Z0KD*-!NU[X99WX.O-9T4<<>S0Z.J3&L 0,!<.?6O3L
M@$J**N'JT@7(;UR\D2=7OAQW.@:K#]<\Z7#"3PTE"XC0MD#+A=4:HQ>,*A.
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MJ $:3D%.!1PN(,) +@?+$VLN8%$V@+[,-$_U=$_Y-$_;1P031 2\QVH:X@'
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M<LD44BLK.V;% :A#P"1M4D$":P3MP2Z@.\)!YRP :RQ :RAW=5FW=3=5BBS
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M?04L)&JH,"N C!"[)D184*O I@+*9D4(D:'"@5JH%G@+M\"&@0 262APM2(
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M4WU*A^'2VC3[4D)5Q88]T=22C?Y)M+$0"2%_(]JY$@:7"6P3+D!4F[A&,JT
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MIN<A K5,E[$JFG%?8N90?]$>3V93T9-YB%$U\21BS#-]6(5UX48F!!,QZR)
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MTIZLV?^<$$$!%D %@6DA%8 )"P<$=;, B#E!&9"0"9 /-L$ -0$ $\H@ *
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MK4^%7NB89U<='4V"EI3_PG3^\V?GN%:7$<OKLR2#@^?!-FB[[>O2'6*+01L
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MB'[\5'.]Q,G]R!8<;5+'*H2KK._L1YN-O;&+<V)@4M=STGL&[G8*G"V6YCC
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M 8(QX!LGM,"VE N'!M ""V@QB8 <J(N2!>""+@P ?\ $(+ 7>X@'!N '+0B
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M#]\)TY]P.)N[$A__^8>P3)(&8#;,"0 &X )HRYP%R(!V"( , (  2 #)80#
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M;N,J+M-8!N-._@@.T>(&N(=T\,(D 8!\..!\& @&X)P'G8=W2&8&P)P##MO
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M?QE_O\JS-46"'V^N95_9>L2/<ADO*+FA@7>0XA6J=X& .>U58$[S-6"$<1N
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M-2FKIT0^5I ^QUT5ZT!:M%.BL\\^BU:=GXUIJ*."P7BA2$5)YJ%@-/['VJ=
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M0.AH"K=VT5-.[+S8=%ZWINQ:R$<+2,<#C"J1A@E*3^R-)$\,$(_&(E@L[6"
M/<3WWLP5;:+ BR@V[Q+6OT+P(D.4X-S.25OL"6";YH&@8N93D\J4MG92 ^R(
MS08?KHY047&35"=)R<4;3_(Z*AL*9Q,"N&[_71:G\SE/13QEGR.MAZQ1] N3
M7C72E&Y19C#:5W=(RF' >FA,:_N,TV;YMJ'ABRT;N&,1$F$$X'A13JQS*G>Q
MNA/BQ+4(A'V=@:!LMYAQ!% :$,$%U$>0I,5U.H-RG%^T$*($([HK1N!'G7B,
MSG8QIEN'5)S:X!-.>:&M6.!MI%_RF1-YW2Y1,Z+T=U74*#,Q\IPN:=3(YL)
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MVR!.36PB4E7;3[5-*G6?GD#,][5*ISF(;C*)BCB'H+5=$#B -_!&JPC L4R
M0C GKFCI>LD)-[(.#,7);YR'UZG=<<1,2CB(=B'$/8RGG-:GH,9G AP:G<KG
M H0( "A ?;IG (S.W"%LPBKL_\(BK)(F"L-";,1*[,12K,(Z['D<K,1>;,5R
M;,)>[,9V;,B*[,B2;,F:;,,R;,8F;+F^B;SI$-&<1Z.=QQB"#\_ "6ZHP\6P
M4W- )3C0%W9:HWH)R@7XTD$0%H- &L0&P#W$J9QRA7D"@)T& +]RQ7JFIP(8
M  2DI]1&;04L0#S$0SJX@]@:@!&T0]BZ0]F>K=BR;3N8;=NBK=J"+=G&@]G&
M@]RVK=G*K=WR[=GVK=GV;=WZ[> *[MW2*=NFK=X"[MFJ+=XF+N':+=S2K7@:
M&-DN[MU&;MJ";>$:6.=N;N8:6-S:+8B(9SI@+N'";>&J[MV*+N,&+N+"[MB.
M+>D6[O_HRBZ<:F[HDBT[M"[I'N[8HFWLXJ[<.B[B[NW:/F[CTBGO&F[EIBV=
MTNGMCB[H9J[E(F\Z,.[O&N_H@JW=QFWS!J[>)@ X^L:\P0D$: 78TJY6&)C>
MEJTEM)^\%:-)M$/9JIT,U:^6WF_+ZD<QXL9QU&_I:@4:Z4?]/J[JXJU[WJO3
MPF< I$4  )*_"@ ]<$V@QF<#T(,"+( !+( 6+, ]Z.8]=/ (B[ 'E_ "_,,'
MC_ _<+ );[ )7X (@_ )M[ *G[ ,K[ *>S *Z_ "Y+ (<S )YS '@[ *!_$-
M]_ ,"_$)I_ ]>+ '&T ,7T -$_$'QW .3_$.@S +3_$(UW#_"AL #-,P"5^Q
M"U.Q"Z/Q!G=Q&N,P%(_P&S_Q!@MQ$$-Q''-P%G]Q$X?P$/,P$8>P;HJQ%3,Q
M&=LP(>/P%G^P'7LQ(6MQ&0OR#SNR!X-Q&C]R'=OP!4PR#P.Q$*=P(L150(VI
MH,!P&%LQ%V^R")M?GA3C$NK)>?GPF!4'![,L_\K0 OSL<VP </Q#$0-Q# 6!
M!^^Q"RNQ"R= TY+G/=## G %G0:J,AL2?=XMU (2!#- >G9:-LX=K"&L-FLS
MP\):-X-SQ#I(-_\%.8<L-XNSPIJSL97SPGZS.R?L.*>S.K<S-F<S.^,S.Z-S
M/<?SQ*YS/O>SQ.[S/1.TM/;S.I/S_S][\]PM@ /XQETIH:"@5T%;S;4&%'+
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ME1ZJ6M;IDM1*C/BC6/CH*V ,=KCE4R)I[ QMC*1G=R2D.;2@':J/,1SB,!;
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M/7(4$<,A8#$ %, '$X!5-+(5^<%T /\@ QK@,!(@ RAB 3:3,[6!,S\3-!?
M,T7S,T=S,TTS-$$3-5-S-4LS-4D3-4US-&?S-.>A,V]3-5WS-4\3-TF3-7>S
M-WES,VT3-VG3-X_S.%>S-7\3.8'3.7/S.873.)DS-*=3.8/3-V-3-V%3.+,3
M.[=S-Z^S.KNS.:D3/,L3/3W3.E]3-ME3.KV3/)US.3L3 (S@!@\3,1A "P(@
M,P/ ,0\#,K5!(R&@%5FD%16@ @P@'=S!".+!" S /A^T02$T'AS402&T'2(T
M'B 40R74'1940BGT0AM40RF40CU41$F40C/T1%<T0CLT'D T0S,T'E@T 6"T
M0UOT11LT1AG_]$1[=$)WE$8MM$&'%$1UM# X5$./E$1I]$8UE$87]$19=$<=
ME$HK5$(WM$@C-$-!U$I#-$O#5$<M=$@;E$F)]$MK=$NU%$V9=$K7=$<AU!U<
MM$5]E$$OU$>-8$ZA%$YMM$-IE$3Q-$P=]$RO]$H]5$:;U$SS=$23E$<1]4[C
M5%&5]$O]=$LI=4GO-$6!E$8[=5$O5449-5"?%$TY]$;7@?KP\Q0#@!X$P#\W
MLD0\TC 7@$ ODR1A(B=RU=L,45>-Q);F@9N\33-TM4=T-2H0Q%A)IU?US5A1
M(W2VBX2"U5B7=5FWSU?7IEB?55L,\%B']85P]22?52T)AUJ]3:E>_\A_ HR1
MI+5<RQ61'D5=O17XH*7H1F)9 <];E>O8A-7;UC7\AM*6E&: IA5=Y55I/,U;
M&6E<@C5>";9855)7@35A)[9;3T5BKY61E#)=_4]8G558SU58Q15D%10_\S-6
M59$D]R$C&4 !M,$_59$6TX%%=H]FC\3P3JR7I S %"? \#!ES.5FFV0E_*O&
MSLM1<C+?1H@S=N]1GDF=9E(=&XF93,\\I.I'!NLF9,*'J&0E+J,EK\9H(.HX
M!$(-=057(.J4I% AL';WQ-!MQH9MD40IR783(821RJQK>\D0MU9G1XBC<*4H
M,45Z=+;F4N\KUHTDL#:/#% D4,@F6LH\H/]-](:V>M@, @GH;"B74N2(ZLS#
M/%;B H*L9%N1%7FP=%O1 ((0=557)&6%SF@$<C!FWZJQ&9E+F<!N00;B2XA"
M=B40[WY"=EWIYR HJ_Y. )P%7]C#\W!7QD;0>N0L.1+%7:3,=U$K[[KN<3JC
M[^9E$Q_QEI)W+JQFG !M*)"WY7@I=^K%=T&(9"H$.HAIX;[UXIXW^&)OUIR+
M5] #05Z0B 0%7SZGUR8IHE2)/90)Y-JP_]IPTO:134*)]5 #@9WOK]P#=DN'
M'487=5:D +.FB&1/+J1+*!S,<\V0?\+FG-QFA N,M)2F.A#*+SY7-JCQ/:"5
M,QY%_#IJYRIN(<S_:;]">%@B*38>1G&^JB^G(O"L-\1BS!ES6$)R!Z'R42#Q
M@WEH"3ID*COJJHB\K)O"$,GN#V<HSU=E9"W*T$GR=@^I$L!NHF7BH@ WXL(B
MU^HX!3\:Y87AZJ4,(!XP^'1BI1_0)(:"HFU<Z7IO:SB^1"FUP1QBBB 5+@))
MD,$8RHX@*4%4R=( 9ZB02'=];8STMRAR1+88^7_LQE!<SN3(:X(?"XS*3&#B
MX[> TLU^)$?<I=5D8N,8Q!??B;F02)NH%_^0)<3:)&SYQ(4^2_[T8LX\T!O%
MAGZ-CIE,\'B]XD&0#M^\,A>5JB%Y1;V:D8BZK%KP6(]EAF;V(:ID<FM)_RO9
MMNE=JO9.9DCA.!&@.B,3PXB(UYDL!P.%<(1G]V1Z2*9 ),>KC(P106=)H(AX
M+8=:@OANQ \X!*>(U P=Y6:\U/G1B,*CM+=3<-FA# JNG(X^5$N9*VQGMJ3=
MC.AMG4\X&CFDL0.(L0/>!&\>&\HK!Q!PU"IM: -_A=:)WAD [J&ZOAEFB$R'
MR>V7I1GV<DN9 9"JW P*.:WN7M=";@DU&@A\P*OG6*E.2ND"1Z;1Q$@=.:,Z
M8J1.?"60,(FQ$!GVS GIZC=7&,(LQJ[TGDSFMAG"O/)X10)+W@J4F:7?+&NK
MN,:B0!KYWJ*TU =[!OELP*LVN)=A*'C>VM&7FO^%F?>-9'HXTF*Y(0S@/GW:
M50R ,IBJ/UK'^- :A5D86XYJ'M%H82I0 ?/K@Y^MB4O)>I^DG_2F2<SB47C#
M1=3L9ARQ(#^ZB]J-$1^0JTIB^;[(MU0[P'S'MXPY$O%&0+BF&#OI,N*I27AQ
M<9&COZBG"AMP(MI0G_5G]]H0G&*X\#@."?6+8^58DKF&#>6V<7N-V!)J=U+E
MHASB E)5LU$$J&]J%WL#\#I%9(Q1IX1(5-[*J<!D2BAYV<;)LJ%Z+KQV+F3)
M=I7'75K0A'6D(@J$;P&0(&]O<+W+GPS$)LZ$8@*&:+9;(.>75GRQF>&JD?K9
M:H2)DTCH2U@YH4SH10+_)9P,$&Q*BVN1!KVR)QYUML[0\=(@>.$2T"3Y0L(,
M42:R!JPEZ7T\^T?:::=%-[]31&8; )_7-HPD$*SLV;PA;Y@;*O0^[LMO(O!T
MYW%W]_7&EEQ$PH\'C_4&<H7;MY1)>=J\.(7F8F7.9JX4ZZ08*<-.ZEHP37TZ
M(IM%R+IER<C>>Z[3R3]ZW/9(1\7D>._B/$=,R)2PUT=&O+ZXA0&C^_5H.X;I
MVI^Z6_U4A3_JK/9:)KZZDCV&+R=(-LM3I C%^;"3O$^HQH&2NGO^KKCQD4&@
MVIE0P[;YQVH<B'^+/9+LS(4[Z7RH6_^@?9^C^*$,!Y91,HW.;&XVN=3@)LT,
M_YR,(L2_-T7_0 UV%'G&$0I?U.G&&>_*Y.^GODZRZR25LKJA)D[?:BN:C([$
M4) &#3!@DT79V.E.3AI?KPJ%T*ETL/S6342#XX:ML37Y7JR1JXKQLM=3#@9;
M8,Z6W^2.PD2T*GT1LVX@-H_&!.9[JAM(]'J?L0/SZHO#NG7J6$IM./[0"*B*
M2.?,O;*?W65?KTJ'"B>0.(B$2&AO^OV& 'VC*/VY+UG7P-OH$;9J/,B?;NVY
M$KKC5OM)2)!=KF8_?BM'?!Y= ,36(]Y$8F569MP$&V2M]\2'_"KNS9[=E&VM
M7F]AS.2_?SAYL#O;RD;#AY:'FC %.1T*<>FM6B[P_/\%0(;W/;A%T:OI*[0P
M[2J<S?6LXRK&!,UU>)O,/2#2*:JLK76E87P\E,0Q:1CP3O;L$8U(X4?0X 4V
M#Z>W@131_>C8H I>I?6-7:*ZXI!'U'5$(!,"R-3^1#@[ !0,&REGB%IKS/?7
M#_O.NJ'?BD**@Q8*/[2.ISJY$LG&;C"*VNI[>8Y$B=UK5XO_KF)^M+H^<RE=
M4>HFPQW(TCFQGTQJA7(:Y!V9KXN+]J<,(.8!" =@ 8!Y! <B/ A &P !#0$4
ME&@PHL.(%2]6A,@QG+F(#\,)%"DQHLB$#@5PY*B08,J)+R-"C"C07$*##E.J
M?,B3)DJ>#@E6K"ASY\*C!!'_"H3H<"$  ^D"2)U*M:K5JUBS:MTZ-0$#B2^=
MAH,X4F!0@0:9\ES)<B?+G& EM@4Z\.-+G6M7*IP(T2--AA,#IUU+^.[!L0_G
M%D[,<Z%?PVJ1@C1[&*)=C')9VJ3+=^]+M8PY7FPZL.U<TC;G(IQID.!EMW%!
M;XQ+LK9>TX3)6LPLD_')PVCC2DQ*\G#=GJ/E2OQ8/&+JT+ !V%RZE^1'R0)S
M]\WN5#KBC3,1-R5HV2_9L3L''OX(F#+(BMG[IA\Z7'=2B0;<<=W/OW__= H$
M0!1]E-7V45LD"9"@=@SMQ%Y@;G447W'%O241=\*1=)%C("4''5W,C<0@6^]=
M&%*#_^8])IUZFV77&H0G'LA;9"%=]M=],<&VH5_D-7C:BHAMU]M.&BHGX7#9
M:52C<4=I-]=@+[)'(TO8):3@=;6519Y:]&'F4$8PXF;A3*2IJ""36X9F''V?
M[:7@/! 1M5-R;;YIW$0G;1;8># !!N9>"UUS)U3^%6IHH>"THX ]#_U)D*!,
M#MG32+>Q%"1FDNK(T$E:PM;::A3U])P P0D6VVUQ-5GG7*,&J=9<Y4T$ZF_I
MC3=G2U2J-]N> %S3UXI?&ND=4.:HY2I+?]FW(FQ]32?I8+8M9JJK>>7&6[ 2
M"7J2D+8A>%Y9)@+6X8KJ\404::@:U9*(T,J89::E"5<I8?]&MKG9:XVY9)Q\
MC('4XW'H]02M8@89T,ZA""><E1$,@#,A<.:&>I];ORV5KDJ6C5NM;L/.U!F"
M(_89V$\\+?ADQQY-G.NKUF9\9)T)P=EOE^UMG"9?'4F)HI1VGNE>8!:GFC)F
M19JVH,JINJF7C?,V3:)3.%F+7=+GE72FH-J<2=]F=D;MG+ZXX9F=R44:!.[$
M"<89ZF<G#]8K0^B:%RG7R48L:V(DJITL2T3=8X3"@ ?>3@:,!DPF<KQ1.V;(
MH$$:M87;JGV17D'K'=.^&(=J*76P(<9YO+<61QUEH)*6K>9XJU<Y79_VJ!NH
MS!(6-61TB?B<24N[;K5QJ7$,[D+_2L:[T%SO;AC;AYKNVYC=]$4K9%KI7:AO
M49Q];5_E,[&&)+TEG56=A?3JMF/L90(,_D6>?ZWFN)?"ZF_0R1D<^/P(&\!
M PW:K;?:[BUE\L;(&LQ%\M<E9-EL2-J+RV!FXAZ5% <O)-H;T*H#/)"<:5-]
M<A_<K#4YN2#-9RT#'[FN1!CV!.L\!](4=0SB-=.=Q76N\8U P$4Q&EI)7ZM#
MD D)4\'L":=)%M/=1#XE/<"8#B$RTMKQ7A:JWK 0:/=)V[)64AO4H6HS39F7
MLT3B0!B!"2DI5!/+Q"@< /PC ?1+HW^\4A]DP:4WJFL)8 2E+MR<RSL]%(X
M/^8[Q?'*_R?-@F-%1D4EDAWN7=8AS@R%,BD$KNEX2E(;O_1"+;:M[2^ =,X2
M6Z:KGB I(8D,&O0L^"LP)4]0P4E/^^;ED-Z5R$NG0\STJ /!D@UO+V^CE:0@
MI)=7[@I]W$I27#JHO5LR2RW,T1S!=J<]S1"',]A3SA[U5A$#&$"-V.0*&XVX
MGB:.DHC&:5.=UF*F)DJ2G/$)#2/)2$(23FPRXYH720@411=Y\$YGFMQOJH67
MMVGR<+FBC&YB%Z$8Z8MN=%SG;FBY0=:9R)2Z<Z;_[,G#)K8)8DWC"=U<YJ;E
M5!2),OD?C9C'&8A BJ$? BDQ=X.W"JUSD*DS90C)>9#TC(EO&_^K'8Y69$S)
MV5*/)7D*&K-)U*L8( ,",M&E/$2\)G4FDF):#JW<2"^X1-"2!/4)FOP)'FN]
MDD\5[,P\-3HDI515=@HDI4FFA2IAYFM3L*M60^[5R6')U%B@">./("FT[?P+
M2A2<*:JL.DQ<^94G=%RB]HHT+F>]Q$ 6+%D@7S)(PT7,A[O9ZR@SAYLMY>J/
M6>770K!H16%IR4;5O&91#=4 JP" *JVEBE?V(<>)XE*%S^S@QW+J-88>DW<<
M])$8-1/8!:VTH']"7Z3@Z12UB0Z43C11!R&U/1#JEK/AQ&.)Y#90:(9$F)OS
M3*BR4RS%47."ZFLK2.!Y(JRJJ96G VG_OWKY.9!J"C2096KQ\D*Y>)YJ>4:3
M[P(1E]."8K>+=[WIW?2IO ";9(=E-,!05\L? 'A%M5*Q7P)>J^'79I@?^#LL
M14ES$;HE,CH14HS$.!9)ZZE)1,3$S1LK JDRQ34Z%W$<[UX*NMA5C"3@>C "
M54*I35W&=+?"T^%&E2\:-0^GDK(=8N3X6Q&^T#ON"\I'P,2I31F8,47^$V!Q
M:ME5(LY9(]LRZBJB(HH&$DRS61RLEFJW<:8+@#]LGU?]XBNX4J]S6"K/\""B
MA8-1F#\2-H "%B"5!3# ?@8 P*.],A5W\,,>9LVN^LQDN<6$UJ>;4Q'B]%:@
MF@PW@6'B<T=C_T<?_*+TN&CU,X\9.V! ]0927"-N!^7+1(T2Q)#Y:_.)./NN
M.\>DE17*2X*XNZ28O/-\'05M@7&:PXGHB6V@:>JFJ=A OQB))346+O@XQ]V+
M(:^(MURAD^A50*E-+R7WP<^$#ZT52;\V 5$)0 *N*6D)!P  _/"P_?X=U((;
MO.#X T _#@Z A-.V) N7"&T?;G"*&]SA$3^XQ??1@'UDG.(6Q]_&)9+PDDQ<
MXB4I.<5+SG"41_SA[W XRAOPCJ!F/*BTK3G.*XYRG@<5?QWW><M3GO.@-YSD
M1U=YRB\^])\WW.@L!P!MHUYPBR-]Z2BW^LQ-?G2I:]WD#X_ZU*^.</^I=QWI
M'.]ZPD5>=JY7O>1 /[C1)1+QC*_]Z#?_.LC?KG&)V(/J)F<YT%DN( S36RL9
M>"T[UB&51PMHTO].?.2[P  &*( !_+B\Y?E1^0Q4_O*:ST#H&>!YSUM^\Z0_
M_>4SX/G1GU[UG.?\ZT7/^=5GGA^UQWSJ09_Z#&0>]0K(/>AS3WKAJ_[SLC=]
MZ_EA>LZW?O?'7SWI?1_]Y']>]Z6WO/*OC_KG!W_SIO^^^#'/^^\K__*_E_[P
M9W_ZYR\?^+4W_OO?C_[VLS_\N=]^]_=???[KW_O])W[$IP#_!W^G%W^D5W[8
M=WWTMX#F%WW\]X#K%WRWMW_JQWH0*'WSUWG_$BA_P-=^^0>!NX> OC=^%<
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M@ $2X86 B6BN:6$WV 63:17:<)<:V1 5P)9:<8)J*1$5H));08&YN0]WR1^
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M%1D@L:B\F1F@F4J*S)9\D V0 >?,%?90S@% #Y>0RX]L%>E@C5+!#@\< .:
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MW?AH^<'=MWK</JT K/[";DI]_6N<_Y5W :B^1M4;DZ".D1FN%>SJ>ZSWY/?
MD95M !Z>%?#JV[M>M)O9>_>CT7&9'\]MH,5NH,39ZC$IB9S'Y5EA84UI,+9.
MW?0+!/RI %;-%4DJNXG=A.R@ +C0[EK1A5+A#NJ+:!.:>O8M>HXM($V8E4B.
M%>'PE!>@ .']PQ[*>CO='T9P>8$M8>X@I7HNTW_]L7@]\*-=**3GYTUL!/D0
MJVND'P'0L:<+! I @!5?802XV?M@!.Z0[__\PXSVD_/.J]FWUUK >@>_TDV(
M 53,'^%0F)+H[O;MA5[([UCQE?1 O;\\L<.!VW-ZHQ>0W%LAKPQ #^M0WP9Z
MER8Y\^4* /_>^;U8D:O@L.\3^['TX)7] 0ZLM_&\OA4Z)VGAGA5L+B"X,.UM
M[Q4NS[KFN;!I[Z@!OQ^IK<85UH1S;]G!ZL6>!^9:D:0EH?7GC0O0V 5_K=%C
M^6@&G0\5D [4:]Y947+_X,/B+A7VD-I.3[^=RY=P?[JKJJ0&?0TWCIF%(N;5
MBNN'_9;+N?!7 =LXC-=1CN[@7 ',%Y+V/9@-R\3CROJB1^PW_NMNRI\1S*K"
M[Z=_.[]=(+$F;..)G!5 3(#8OQ7_ /W;O-M2$0ZL3\ZMS?P&_0ZLQWP5,.?D
M;)==0/Q64:D 8:!" ((%#1X,< ]#A@P5$B"$6' !!@7\%NZ+F%'_XT:.'2-J
M<8AA09>''A-4RI" #! &_SHF8! S)@"/!N_%7%"3((,*]!AHZ9+3(P:6^8#@
M2B!4(P"8,DOJU!;3@$Z"&/AE,$"O L:.]G#AHL?ODD.:&Q?(E$HU@ $&$)2:
MK," 'M"R'1< (8GA$H9V'=FB?6N208*Z'N-BU:J3W:64*QE,Y=@T)H3"'0%
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9Q$ "L;E.=K;3G>^$9SSE.4]ZUA-[ 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">4,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 4,820,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 665.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 4,820,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">665.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">665.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 4,820,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236924_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236924_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236924_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236924_exfilingfees.htm">dp236924_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236924_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236924_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236924_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950103-25-014261-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014261-xbrl.zip
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MTIP8<XC@.M-SAQOQG*1S6HCGA<;G)97+'<PC-9ID08<A35C(R@@0 G:[YG)
M6 @ I7\0;%:/$#H35%BD"M$ @HS<F/PL&]R2BS81&$E4:?+? 1V>*W+S$4>D
M9>10D!%<G2N"C$76=Z>L_UPV0'_6<<T)XF)BD7.E"\"PNU5/H#:U"4<M,D*W
MKHV=5' C!1[/:!>X.SHSZ3!\SJ0<8M&D@AS7(8J/GHXKD@!A\FIZ34V3.,%U
M< ? 6P,;,!K(@4T$#'3-RMV@8U/.G;8WY7XL;DGW7#&^,N*Y3"B(@O+H>)C6
M-4VIYO7\A7Z6G<.VD08H<1K<DE#1E>J[QW2C>=UL7:'&NW=WVY #TU?>.6"O
M21WLP+#5=$PR_D FF^GFE*H*?TYRFJIJVXIX2WJ.3""MSF9"X&ZY7"ZME]2<
M7EI%*+M@0DF9D2YAD/\(C\#DGJAPHT]L#/20'Y8J?29)2R_EJSQ>_DC+'YDQ
M-Y7I<P)\^%SA%%(="?PV8F61=, .=P<LSHT?""M3^7V)C:]N%YZ$K?154T*X
M")+XEIK=CA:H*9>ZE##D"T>6QI9Z\\.\S18?7H*9DYX-R_&5Z9I)?068'XG=
M ;HF[$#'KSM\ ]],Q:B-*5>J9]+/9&!KN56@&[LZR[[$M4 LNY*3<&E1+U/>
M/># -9<))3 3EU">5,&DA;2FI=5\1"9:>_D<<<P53X4K2YA;Y"*\/S5[,F?0
M?U%GT/]VAL3.,(V,/]81?CTE#QP::/C^[O*E<FV"^8"1ZK1LK !0B"Y<>D%'
M8EQ%Q(,G5E.9\@\_OXL([V-(-IO(!%#;$<J^S&-!ZHVJ*=C0="@K,"^LOVS,
M>M1)"]>K("C>3M'T1L<5PK6AHM/E35G=I3G]1L(;TE1I;-$>M'2,]OHAS(C(
MBPKJN)8)I<\X/5=Z>EN1+FZD;("G$[:4=+UV7;^_KK6;-RUTTT"S"@RU:Q?7
ML@X[(#.KBTEH(!*4D?D3I7J7SBV65]O*H'Z70JF@/>8./'1EN1ULH8^8/1/!
MT7M8!A-SU'2,S+8L)7"O;?4ZJYJACJ5<-FI"]MF;M5R.2PG2+.H[DT*8HZL!
MEBA=MBAKQV6PS0)9KQB>H!PT0Z8[Z%AD7D1-BNAA4ZHM "\F%CK2X$J5YCU(
M0VT,5)%6D6V8-4&!)J#H-1%V3%3'C$WD2&B$F0E]F3%@('>T0X7_L$$L:\KD
MN:(J_C7WL!%>QQJ_4#"?G:D:#->RL,?A=OCK%(VH*?H23OV7[%(%6X+$M_^0
M,$$-;(7J"&1+[!=^YVN&R$.J.A#]]S^UHGH*3;"Y'$C-%!) :4F #HZJF @J
M&:Z3G6$J[TY5"6!V:)B#RG98OA>L"_^P5=OQ9.?;<1H?PG!U86'C&4%(1-RU
M*$!?0[N!FH+82(ZAE@@11LXHA\B MU+D3>2FT6]R8&IU"W..VG(6MW>B+5?X
M@[_]4I%C_SJVC('ECT3/.BQ;1;># \A7L]V!(V))+H9C"5;(1Y#'H/O5E:04
M/C'7<SEDSX]X3.V!C<*F.9#R$U0'!'V"5NX>ZO&=4P^)UGH]1GKRM5!(/J!\
M$-/> MV=2S:UG-M%8:TF74=V"QL#T](Z 8JB^:ADD:Y05K+\]YW#WWEATZUL
M&'.RF9?-E=*QAD*N5A 5@,=8GJP6MXDNM\F+DCE>('^_!&$J[E-!TK*@)O+E
MQXAA;TVC^(F1(;<FG\R&U5ML9&)#:12\D9(-C:AT7-<BV.EB2[YFBMJ<@NIO
M: YLH@Y$+4S-EXWENGW^*@'"B'5GB,G+CC<NPHQ13:E>DH[8BKN$'$#>3<:#
MGK3S11^)20=VNDV8#1[C4)<A/_$&+[[D&[%7J?FEVRK58^WMJY]=_=8'4G6^
M4&+;>YA@@SD'RRE50'3,WGZWP/YH*>*YP;#AYX<9TS5;@#U!N[!=307)<9C/
M\W3(ADQB4!LV@-^QQEEW!K;IBNER,E?(@UBI$UT-I0K9V>"0OWVOC)#^0]^5
MZ1[*#.G",6'E;#0F:;/5^&Y9"TI52ZGJCY 5JAP1EW>_@A:G1MU>V 2;;(F
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<97,N:'1M4$L%!@     !  $ 1P   (8+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>dp236924_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">4820</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">4820000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">665.64</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">4820000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">665.64</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">665.64</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">4820000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
